Index NDX, S&P 500
P/E 81.01
EPS (ttm) 5.82
Insider Own 0.66%
Shs Outstand 355.35M
Perf Week -3.15%
Market Cap 167.66B
Forward P/E 61.73
EPS next Y 7.64
Insider Trans -5.20%
Shs Float 353.01M
Perf Month 5.02%
Income 2.09B
PEG 5.75
EPS next Q 1.64
Inst Own 87.23%
Short Float 1.06%
Perf Quarter 12.84%
Sales 7.57B
P/S 22.14
EPS this Y 16.23%
Inst Trans -0.44%
Short Ratio 2.49
Perf Half Y 20.15%
Book/sh 41.40
P/B 11.40
EPS next Y 15.16%
ROA 13.71%
Short Interest 3.74M
Perf Year 53.27%
Cash/sh 13.39
P/C 35.24
EPS next 5Y 14.09%
ROE 15.75%
52W Range 254.85 - 493.97
Perf YTD 39.86%
Dividend Est. -
P/FCF 399.67
EPS past 5Y 9.71%
ROI 14.23%
52W High -4.48%
Beta 1.40
Dividend TTM -
Quick Ratio 4.22
Sales past 5Y 14.41%
Gross Margin 66.86%
52W Low 85.14%
ATR (14) 10.08
Dividend Ex-Date -
Current Ratio 5.15
EPS Y/Y TTM 46.37%
Oper. Margin 25.79%
RSI (14) 49.72
Volatility 2.16% 1.81%
Employees 13676
Debt/Eq 0.00
Sales Y/Y TTM 13.62%
Profit Margin 27.65%
Recom 2.00
Target Price 491.08
Option/Short Yes / Yes
LT Debt/Eq 0.00
EPS Q/Q 23.94%
Payout 0.00%
Rel Volume 1.11
Prev Close 476.69
Sales Surprise 1.94%
EPS Surprise 15.45%
Sales Q/Q 14.47%
Earnings Jul 18 AMC
Avg Volume 1.50M
Price 471.82
SMA20 -1.57%
SMA50 3.15%
SMA200 19.47%
Trades
Volume 1,666,887
Change -1.02%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-02-24 Upgrade
Redburn Atlantic
Neutral → Buy
$380 → $510
Jul-10-24 Reiterated
Citigroup
Buy
$462 → $512
May-30-24 Initiated
Goldman
Buy
$500
Nov-17-23 Initiated
HSBC Securities
Buy
$318
Jul-19-23 Initiated
Robert W. Baird
Outperform
$377
Apr-19-23 Reiterated
Wells Fargo
Overweight
$289 → $310
Apr-19-23 Reiterated
Truist
Buy
$300 → $325
Apr-19-23 Reiterated
Stifel
Buy
$285 → $315
Apr-19-23 Reiterated
RBC Capital Mkts
Outperform
$305 → $309
Apr-19-23 Reiterated
Raymond James
Outperform
$270 → $323
Apr-19-23 Reiterated
Morgan Stanley
Equal-Weight
$265 → $285
Apr-19-23 Reiterated
JP Morgan
Overweight
$250 → $335
Apr-19-23 Reiterated
Evercore ISI
In-line
$240 → $270
Apr-19-23 Reiterated
Citigroup
Buy
$305 → $317
Apr-19-23 Reiterated
BTIG Research
Buy
$284 → $313
Apr-19-23 Reiterated
BofA Securities
Buy
$300 → $315
Mar-29-23 Initiated
UBS
Neutral
$278
Mar-23-23 Initiated
William Blair
Outperform
Oct-18-22 Initiated
Barclays
Overweight
$235
Oct-13-22 Initiated
Mizuho
Neutral
$215
Show Previous Ratings
Sep-06-24 07:51AM
Sep-05-24 05:50PM
08:00AM
Sep-04-24 06:00PM
Sep-02-24 05:07PM
09:00AM
Loading…
Aug-30-24 09:00AM
Aug-29-24 05:50PM
Aug-28-24 06:53PM
09:00AM
Aug-26-24 08:15AM
Aug-23-24 05:50PM
Aug-22-24 08:00AM
Aug-20-24 05:06AM
01:27AM
Aug-16-24 01:27PM
09:30AM
Loading…
Aug-15-24 09:30AM
06:15AM
Aug-14-24 10:41AM
09:00AM
Aug-13-24 04:30PM
12:20PM
03:32AM
Aug-11-24 07:33AM
06:14AM
Aug-10-24 05:39PM
11:29AM
11:28AM
Aug-08-24 08:00AM
Aug-07-24 09:00AM
Aug-06-24 07:55AM
07:45AM
Loading…
Aug-05-24 07:45AM
Aug-04-24 10:45AM
Aug-03-24 06:38AM
Aug-02-24 07:03PM
09:42AM
09:00AM
Aug-01-24 09:45AM
Jul-28-24 10:00AM
Jul-27-24 08:45AM
05:55AM
Jul-26-24 09:30AM
06:35AM
05:27AM
Jul-25-24 09:00AM
06:11AM
Jul-23-24 12:00PM
09:40AM
Jul-22-24 11:01PM
02:59PM
(Investor's Business Daily)
01:24PM
09:35AM
09:30AM
Jul-21-24 05:06AM
Jul-20-24 08:00AM
(Investor's Business Daily)
Jul-19-24 05:40PM
(Yahoo Finance Video) +9.34%
04:43PM
04:42PM
04:38PM
(Investor's Business Daily)
02:34PM
01:51PM
01:49PM
01:41PM
12:59PM
(Associated Press Finance)
09:46AM
(Thomson Reuters StreetEvents)
09:00AM
07:21AM
07:09AM
Jul-18-24 11:00PM
08:53PM
06:00PM
05:15PM
04:58PM
(Investor's Business Daily)
04:53PM
04:05PM
01:14PM
01:07PM
12:36PM
10:32AM
Jul-17-24 04:05PM
Jul-16-24 09:10AM
Jul-14-24 07:00AM
07:00AM
Jul-13-24 12:05PM
Jul-12-24 08:00AM
Jul-11-24 09:10AM
Jul-10-24 03:22PM
Jul-09-24 06:00PM
Jul-08-24 10:28AM
Jul-05-24 08:11AM
06:44AM
Jul-04-24 07:47AM
Jul-03-24 06:26AM
06:00AM
Jul-02-24 09:05AM
Jul-01-24 12:33PM
09:45AM
Jun-30-24 07:52AM
Jun-28-24 05:47PM
05:20PM
08:00AM
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
DeSantis Robert EVP & Chief Strategy & Corp Op Aug 28 '24 Option Exercise 290.33 188 54,582 5,694 Aug 29 05:49 PM DeSantis Robert EVP & Chief Strategy & Corp Op Aug 29 '24 Option Exercise 208.90 188 39,273 5,694 Aug 29 05:49 PM DeSantis Robert EVP & Chief Strategy & Corp Op Aug 28 '24 Sale 482.93 188 90,791 5,506 Aug 29 05:49 PM DeSantis Robert EVP & Chief Strategy & Corp Op Aug 29 '24 Sale 482.21 188 90,655 5,506 Aug 29 05:49 PM ROBERT DESANTIS Officer Aug 29 '24 Proposed Sale 482.21 188 90,655 Aug 29 04:16 PM ROBERT DESANTIS Officer Aug 28 '24 Proposed Sale 482.93 188 90,791 Aug 28 04:22 PM DeSantis Robert EVP & Chief Strategy & Corp Op Aug 26 '24 Option Exercise 296.51 396 117,417 5,704 Aug 26 06:49 PM DeSantis Robert EVP & Chief Strategy & Corp Op Aug 26 '24 Sale 486.88 396 192,804 5,506 Aug 26 06:49 PM Charlton Henry L SVP & Chief Commercial and Mkt Aug 23 '24 Option Exercise 142.20 19,758 2,809,518 28,689 Aug 26 05:04 PM Charlton Henry L SVP & Chief Commercial and Mkt Aug 23 '24 Sale 486.84 40,243 19,591,843 3,001 Aug 26 05:04 PM ROBERT DESANTIS Officer Aug 26 '24 Proposed Sale 486.88 396 192,804 Aug 26 04:03 PM HENRY CHARLTON Officer Aug 23 '24 Proposed Sale 486.84 40,243 19,591,840 Aug 23 04:13 PM DeSantis Robert EVP & Chief Strategy & Corp Op Aug 12 '24 Option Exercise 267.03 240 64,087 5,626 Aug 13 02:13 PM DeSantis Robert EVP & Chief Strategy & Corp Op Aug 12 '24 Sale 464.76 240 111,542 5,506 Aug 13 02:13 PM ROBERT DESANTIS Officer Aug 12 '24 Proposed Sale 464.76 240 111,542 Aug 12 04:10 PM Johnson Amal M Director Aug 01 '24 Option Exercise 71.32 2,943 209,904 15,218 Aug 05 01:10 PM Johnson Amal M Director Aug 01 '24 Sale 443.30 2,943 1,304,632 12,275 Aug 05 01:10 PM AMAL M JOHNSON Director Aug 01 '24 Proposed Sale 443.30 2,943 1,304,632 Aug 01 04:15 PM GUTHART GARY S CEO Jul 30 '24 Option Exercise 57.11 25,200 1,439,200 40,558 Jul 31 01:24 PM GUTHART GARY S CEO Jul 30 '24 Sale 443.07 23,388 10,362,516 17,170 Jul 31 01:24 PM GUTHART GARY S CEO Jul 30 '24 Sale 445.09 7,440 3,311,480 23,640 Jul 31 01:24 PM GARY S GUTHART Officer Jul 30 '24 Proposed Sale 443.07 23,388 10,362,514 Jul 30 04:38 PM DeSantis Robert EVP & Chief Strategy & Corp Op Jul 26 '24 Option Exercise 279.09 1,413 394,347 5,905 Jul 30 02:02 PM DeSantis Robert EVP & Chief Strategy & Corp Op Jul 29 '24 Option Exercise 249.61 376 93,855 5,694 Jul 30 02:02 PM DeSantis Robert EVP & Chief Strategy & Corp Op Jul 26 '24 Sale 438.60 1,413 619,742 5,506 Jul 30 02:02 PM DeSantis Robert EVP & Chief Strategy & Corp Op Jul 29 '24 Sale 446.60 376 167,922 5,506 Jul 30 02:02 PM GUTHART GARY S Officer Jul 30 '24 Proposed Sale 442.05 7,440 3,288,852 Jul 30 10:55 AM ROBERT DESANTIS Officer Jul 29 '24 Proposed Sale 446.60 376 167,922 Jul 29 04:36 PM ROBERT DESANTIS Officer Jul 26 '24 Proposed Sale 438.60 1,413 619,742 Jul 26 04:35 PM BARRATT CRAIG H Director Jul 23 '24 Option Exercise 56.97 1,400 79,764 1,400 Jul 24 02:06 PM BARRATT CRAIG H Director Jul 23 '24 Sale 458.13 1,400 641,382 0 Jul 24 02:06 PM Curet Myriam EVP & Chief Medical Officer Jul 23 '24 Option Exercise 177.99 2,818 501,567 3,116 Jul 24 01:47 PM Curet Myriam EVP & Chief Medical Officer Jul 23 '24 Sale 458.13 2,818 1,291,010 298 Jul 24 01:47 PM BARRATT CRAIG H Director Jun 12 '24 Option Exercise 56.97 1,400 79,764 1,400 Jun 12 09:18 PM BARRATT CRAIG H Director Jun 12 '24 Sale 421.06 1,400 589,484 0 Jun 12 09:18 PM DeSantis Robert EVP & Chief Strategy & Corp Op Jun 10 '24 Option Exercise 266.87 239 63,783 5,626 Jun 11 12:17 PM DeSantis Robert EVP & Chief Strategy & Corp Op Jun 10 '24 Sale 416.60 239 99,567 5,506 Jun 11 12:17 PM Rosa David J. President Jun 10 '24 Option Exercise 0.00 1,359 0 216,644 Jun 10 10:35 AM BARRATT CRAIG H Director Jun 05 '24 Option Exercise 56.97 1,400 79,764 1,400 Jun 06 06:35 PM BARRATT CRAIG H Director Jun 05 '24 Sale 411.00 1,400 575,400 0 Jun 06 06:35 PM BARRATT CRAIG H Director Jun 03 '24 Option Exercise 56.97 2,496 142,208 1,400 Jun 03 08:16 PM BARRATT CRAIG H Director Jun 03 '24 Sale 402.89 2,496 1,005,613 0 Jun 03 08:16 PM DeSantis Robert EVP & Chief Strategy & Corp Op May 28 '24 Option Exercise 294.52 584 171,999 5,704 May 30 01:20 PM DeSantis Robert EVP & Chief Strategy & Corp Op May 29 '24 Option Exercise 208.90 188 39,273 5,694 May 30 01:20 PM DeSantis Robert EVP & Chief Strategy & Corp Op May 28 '24 Sale 404.41 584 236,175 5,506 May 30 01:20 PM DeSantis Robert EVP & Chief Strategy & Corp Op May 29 '24 Sale 396.59 188 74,559 5,506 May 30 01:20 PM Brosius Mark SVP & Chief Mfg and Supply Cha May 16 '24 Sale 398.28 175 69,699 358 May 17 06:05 PM Brosius Mark SVP & Chief Mfg and Supply Cha May 17 '24 Sale 396.19 63 24,960 295 May 17 06:05 PM Miller Brian Edward EVP & Chief Digital Officer May 16 '24 Sale 400.00 2,553 1,021,200 9,619 May 17 04:33 PM Brosius Mark SVP & Chief Mfg and Supply Cha May 13 '24 Sale 389.16 175 68,103 883 May 15 05:39 PM Brosius Mark SVP & Chief Mfg and Supply Cha May 15 '24 Sale 387.22 175 67,764 533 May 15 05:39 PM Brosius Mark SVP & Chief Mfg and Supply Cha May 14 '24 Sale 380.85 175 66,649 708 May 15 05:39 PM DeSantis Robert EVP & Chief Strategy & Corp Op May 10 '24 Option Exercise 267.19 239 63,858 5,627 May 14 04:57 PM DeSantis Robert EVP & Chief Strategy & Corp Op May 13 '24 Option Exercise 179.70 90 16,173 5,790 May 14 04:57 PM DeSantis Robert EVP & Chief Strategy & Corp Op May 11 '24 Option Exercise 0.00 360 0 5,867 May 14 04:57 PM DeSantis Robert EVP & Chief Strategy & Corp Op May 13 '24 Sale 389.16 284 110,521 5,506 May 14 04:57 PM DeSantis Robert EVP & Chief Strategy & Corp Op May 10 '24 Sale 385.55 239 92,146 5,507 May 14 04:57 PM RUBASH MARK J Director May 03 '24 Option Exercise 295.92 1,709 505,727 17,760 May 06 02:18 PM RUBASH MARK J Director May 03 '24 Sale 380.00 1,709 649,420 16,051 May 06 02:18 PM DeSantis Robert EVP & Chief Strategy & Corp Op Apr 26 '24 Option Exercise 273.00 1,498 408,950 5,903 Apr 30 01:36 PM DeSantis Robert EVP & Chief Strategy & Corp Op Apr 29 '24 Option Exercise 249.61 376 93,855 5,695 Apr 30 01:36 PM DeSantis Robert EVP & Chief Strategy & Corp Op Apr 26 '24 Sale 369.92 1,498 554,146 5,507 Apr 30 01:36 PM DeSantis Robert EVP & Chief Strategy & Corp Op Apr 29 '24 Sale 375.39 376 141,147 5,507 Apr 30 01:36 PM RUBASH MARK J Director Apr 25 '24 Option Exercise 0.00 569 0 16,051 Apr 29 05:15 PM NACHTSHEIM JAMI K Director Apr 25 '24 Option Exercise 0.00 569 0 5,632 Apr 26 08:41 PM Kolli Sreelakshmi Director Apr 25 '24 Option Exercise 0.00 240 0 240 Apr 26 08:34 PM KANIA DON R Director Apr 25 '24 Option Exercise 0.00 569 0 3,838 Apr 26 08:08 PM Johnson Amal M Director Apr 25 '24 Option Exercise 0.00 569 0 12,275 Apr 26 05:03 PM Ladd Amy L Director Apr 25 '24 Option Exercise 0.00 569 0 1,271 Apr 26 04:12 PM Leonard Keith R Director Apr 25 '24 Option Exercise 0.00 569 0 1,606 Apr 26 03:44 PM Beery Joseph C Director Apr 25 '24 Option Exercise 0.00 569 0 2,371 Apr 26 03:09 PM BARRATT CRAIG H Director Apr 25 '24 Option Exercise 0.00 804 0 26,155 Apr 26 02:57 PM Reed Monica P Director Apr 25 '24 Option Exercise 0.00 569 0 1,606 Apr 26 02:47 PM LEVY ALAN J Director Apr 25 '24 Option Exercise 0.00 569 0 25,888 Apr 26 02:38 PM LEVY ALAN J Director Apr 23 '24 Option Exercise 154.24 2,000 308,473 27,319 Apr 24 02:22 PM LEVY ALAN J Director Apr 23 '24 Sale 370.70 2,000 741,398 25,319 Apr 24 02:22 PM Curet Myriam EVP & Chief Medical Officer Apr 23 '24 Option Exercise 180.27 5,318 958,650 3,116 Apr 24 01:18 PM Curet Myriam EVP & Chief Medical Officer Apr 23 '24 Sale 370.66 5,318 1,971,160 298 Apr 24 01:18 PM Widman Fredrik VP Corporate Controller Mar 15 '24 Option Exercise 59.23 1,224 72,495 722 Mar 18 02:35 PM Widman Fredrik VP Corporate Controller Mar 15 '24 Sale 397.07 5,041 2,001,630 110 Mar 18 02:35 PM DeSantis Robert EVP & Chief Strategy & Corp Op Mar 08 '24 Option Exercise 297.63 14,728 4,383,438 18,224 Mar 11 08:11 PM DeSantis Robert EVP & Chief Strategy & Corp Op Mar 11 '24 Option Exercise 243.03 329 79,956 5,627 Mar 11 08:11 PM DeSantis Robert EVP & Chief Strategy & Corp Op Mar 08 '24 Sale 393.80 20,296 7,992,510 5,507 Mar 11 08:11 PM DeSantis Robert EVP & Chief Strategy & Corp Op Mar 11 '24 Sale 390.16 329 128,363 5,507 Mar 11 08:11 PM Brosius Mark SVP & Chief Mfg and Supply Cha Mar 08 '24 Sale 392.02 196 76,836 1,254 Mar 11 04:43 PM Brosius Mark SVP & Chief Mfg and Supply Cha Mar 11 '24 Sale 390.16 196 76,471 1,058 Mar 11 04:43 PM Brosius Mark SVP & Chief Mfg and Supply Cha Mar 05 '24 Sale 400.00 196 78,400 1,842 Mar 07 05:17 PM Brosius Mark SVP & Chief Mfg and Supply Cha Mar 07 '24 Sale 393.30 196 77,087 1,450 Mar 07 05:17 PM Brosius Mark SVP & Chief Mfg and Supply Cha Mar 06 '24 Sale 386.76 196 75,805 1,646 Mar 07 05:17 PM Curet Myriam EVP & Chief Medical Officer Mar 01 '24 Sale 383.48 1,605 615,485 298 Mar 01 06:11 PM GUTHART GARY S CEO Feb 29 '24 Option Exercise 0.00 6,370 0 16,629 Mar 01 01:01 PM Samath Jamie Chief Financial Officer Feb 29 '24 Option Exercise 0.00 2,006 0 9,139 Feb 29 07:48 PM Brosius Mark SVP & Chief Mfg and Supply Cha Feb 29 '24 Option Exercise 0.00 1,843 0 2,483 Feb 29 07:38 PM Miller Brian Edward EVP & Chief Digital Officer Feb 29 '24 Option Exercise 0.00 2,817 0 13,028 Feb 29 07:26 PM MOHR MARSHALL Executive VP Global Business S Feb 28 '24 Option Exercise 142.35 129,810 18,478,437 58,397 Feb 29 07:17 PM MOHR MARSHALL Executive VP Global Business S Feb 29 '24 Option Exercise 0.00 3,256 0 50,150 Feb 29 07:17 PM MOHR MARSHALL Executive VP Global Business S Feb 28 '24 Sale 385.08 108,790 41,893,066 26,877 Feb 29 07:17 PM Charlton Henry L SVP & Chief Commercial and Mkt Feb 29 '24 Option Exercise 0.00 2,201 0 23,824 Feb 29 06:56 PM DeSantis Robert EVP & Chief Strategy & Corp Op Feb 29 '24 Option Exercise 0.00 3,676 0 11,772 Feb 29 05:16 PM Curet Myriam EVP & Chief Medical Officer Feb 29 '24 Option Exercise 0.00 3,256 0 3,045 Feb 29 05:00 PM
Index -
P/E -
EPS (ttm) -2.86
Insider Own 55.81%
Shs Outstand 155.89M
Perf Week -11.91%
Market Cap 34.04M
Forward P/E -
EPS next Y -8.97
Insider Trans -2.88%
Shs Float 2.61M
Perf Month -3.83%
Income -61.02M
PEG -
EPS next Q -2.57
Inst Own 14.71%
Short Float 4.81%
Perf Quarter -45.97%
Sales 0.00M
P/S -
EPS this Y 32.44%
Inst Trans 5.31%
Short Ratio 2.95
Perf Half Y -45.81%
Book/sh 12.22
P/B 0.47
EPS next Y 14.91%
ROA -61.68%
Short Interest 0.13M
Perf Year -79.61%
Cash/sh 12.41
P/C 0.46
EPS next 5Y -
ROE -82.71%
52W Range 4.27 - 29.76
Perf YTD -47.55%
Dividend Est. -
P/FCF -
EPS past 5Y -
ROI -71.74%
52W High -80.61%
Beta 1.12
Dividend TTM -
Quick Ratio 10.57
Sales past 5Y 0.00%
Gross Margin -
52W Low 35.13%
ATR (14) 0.62
Dividend Ex-Date -
Current Ratio 10.57
EPS Y/Y TTM -356.06%
Oper. Margin 0.00%
RSI (14) 40.24
Volatility 8.01% 10.28%
Employees 131
Debt/Eq 0.20
Sales Y/Y TTM -
Profit Margin -
Recom 2.50
Target Price 9.50
Option/Short No / Yes
LT Debt/Eq 0.18
EPS Q/Q -2043.21%
Payout -
Rel Volume 0.33
Prev Close 5.96
Sales Surprise -
EPS Surprise -5.15%
Sales Q/Q -
Earnings Aug 12 AMC
Avg Volume 42.53K
Price 5.77
SMA20 -7.07%
SMA50 -16.96%
SMA200 -39.49%
Trades
Volume 14,173
Change -3.19%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-04-22 Downgrade
Piper Sandler
Overweight → Neutral
$16 → $7
Jan-07-22 Initiated
Credit Suisse
Outperform
$16
Dec-07-21 Initiated
Cowen
Outperform
$15
Nov-05-21 Initiated
Canaccord Genuity
Buy
$15
Oct-18-21 Initiated
BTIG Research
Buy
$15
Oct-07-21 Initiated
Piper Sandler
Overweight
$16
Aug-21-24 08:30AM
Aug-12-24 04:05PM
(Business Wire) -9.39%
-5.27%
Aug-07-24 08:30AM
Jul-29-24 04:10PM
Jun-10-24 04:15PM
(Business Wire) +6.72%
-18.88%
07:23AM
Loading…
May-22-24 07:23AM
May-01-24 09:36AM
Apr-30-24 03:05AM
Apr-29-24 08:54PM
04:05PM
Apr-08-24 04:30PM
(Business Wire) +8.69%
+14.17%
Mar-04-24 04:10PM
Feb-20-24 08:30AM
Feb-12-24 04:30PM
Jan-29-24 08:30AM
08:30AM
Loading…
Nov-15-23 08:30AM
Nov-14-23 08:45AM
Nov-13-23 04:05PM
Oct-26-23 09:00AM
Sep-22-23 05:00PM
Sep-12-23 08:00AM
Sep-07-23 04:30PM
Aug-03-23 04:30PM
Aug-02-23 10:25PM
04:45PM
Jul-27-23 04:05PM
(Business Wire) -13.00%
-5.75%
Jul-13-23 04:15PM
May-18-23 04:05PM
May-08-23 04:05PM
May-04-23 09:00AM
04:30PM
Loading…
Apr-24-23 04:30PM
Feb-22-23 09:00AM
Feb-13-23 04:05PM
Jan-30-23 09:00AM
Jan-23-23 04:10PM
Dec-22-22 06:46PM
Nov-17-22 09:00AM
Nov-14-22 08:30AM
Nov-10-22 09:25AM
Nov-07-22 04:05PM
08:00AM
Oct-24-22 08:00AM
Oct-20-22 04:15PM
Oct-13-22 08:00AM
Aug-17-22 04:15PM
Aug-08-22 04:05PM
Jul-27-22 04:15PM
Jul-25-22 04:15PM
Jul-07-22 04:05PM
(Business Wire) +15.86%
+7.44%
Jun-21-22 09:00AM
Jun-08-22 04:30PM
(Business Wire) -5.16%
-10.62%
May-09-22 04:05PM
(Business Wire) -11.66%
-10.11%
May-08-22 09:06AM
Apr-18-22 04:15PM
Mar-29-22 04:34PM
Mar-24-22 05:30PM
Mar-03-22 04:05PM
(Business Wire) -7.26%
-14.63%
Mar-01-22 08:00AM
Feb-23-22 04:10PM
Feb-02-22 04:10PM
Jan-24-22 01:38PM
Jan-05-22 09:35AM
Dec-06-21 09:43AM
Nov-10-21 04:10PM
Nov-08-21 04:05PM
Nov-04-21 04:10PM
02:47PM
Oct-28-21 04:10PM
Oct-21-21 04:30PM
Oct-20-21 04:10PM
Sep-21-21 08:00AM
Vicarious Surgical, Inc. a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It also designs surgical robotics. The company was founded by Adam Sachs, Sammy Khalifa, and Barry Greene on May 1, 2014 and is headquartered in Waltham, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Sachs Adam David CEO Sep 03 '24 Sale 5.88 396 2,327 55,200 Sep 05 05:15 PM Mazzola John Chief Operating Officer Sep 03 '24 Sale 5.82 195 1,135 9,990 Sep 05 05:15 PM Kelly William John CFO and Treasurer Sep 03 '24 Sale 5.80 186 1,078 12,624 Sep 05 05:15 PM Khalifa Sammy Chief Technology Officer Sep 03 '24 Sale 5.88 204 1,199 38,797 Sep 05 05:14 PM Adam Sachs Officer Sep 03 '24 Proposed Sale 6.31 396 2,499 Sep 03 12:59 PM Sammy Khalifa Officer Sep 03 '24 Proposed Sale 6.31 204 1,287 Sep 03 12:59 PM John Mazzola Officer Sep 03 '24 Proposed Sale 6.31 195 1,230 Sep 03 12:59 PM William Kelly Officer Sep 03 '24 Proposed Sale 6.31 186 1,174 Sep 03 12:59 PM Sachs Adam David CEO Aug 20 '24 Sale 6.32 698 4,413 55,596 Aug 21 01:23 PM Khalifa Sammy Chief Technology Officer Aug 20 '24 Sale 6.29 559 3,516 39,001 Aug 21 01:21 PM Kelly William John CFO and Treasurer Aug 20 '24 Sale 6.30 93 586 13,893 Aug 21 01:20 PM Adam Sachs Officer Aug 20 '24 Proposed Sale 6.58 698 4,593 Aug 20 02:44 PM William Kelly Officer Aug 20 '24 Proposed Sale 6.58 93 612 Aug 20 01:22 PM Sammy Khalifa Officer Aug 20 '24 Proposed Sale 6.58 559 3,678 Aug 20 01:13 PM Sachs Adam David CEO Jul 18 '24 Sale 7.96 100 796 56,294 Jul 22 02:38 PM Khalifa Sammy Chief Technology Officer Jul 18 '24 Sale 7.96 80 637 39,560 Jul 22 02:37 PM Kelly William John CFO and Treasurer Jul 18 '24 Sale 7.97 27 215 16,798 Jul 22 02:35 PM Mazzola John Chief Operating Officer Jun 03 '24 Sale 0.32 6,854 2,203 305,593 Jun 04 03:24 PM Khalifa Sammy Chief Technology Officer Jun 03 '24 Sale 0.32 7,167 2,303 1,189,209 Jun 04 03:24 PM Kelly William John CFO and Treasurer Jun 03 '24 Sale 0.32 6,528 2,097 504,767 Jun 04 03:23 PM Sachs Adam David CEO Jun 03 '24 Sale 0.32 13,896 4,469 1,691,822 Jun 04 03:23 PM Sachs Adam David CEO May 20 '24 Sale 0.39 24,502 9,507 1,705,718 May 21 01:43 PM Khalifa Sammy Chief Technology Officer May 20 '24 Sale 0.39 19,601 7,607 1,196,376 May 21 01:43 PM Kelly William John CFO and Treasurer May 20 '24 Sale 0.39 6,546 2,540 511,295 May 21 01:42 PM Sachs Adam David CEO Mar 20 '24 Sale 0.34 4,830 1,653 1,730,220 Mar 21 03:53 PM Khalifa Sammy Chief Technology Officer Mar 20 '24 Sale 0.34 3,863 1,316 1,215,977 Mar 21 03:53 PM Kelly William John CFO and Treasurer Mar 20 '24 Sale 0.34 1,290 437 517,841 Mar 21 03:53 PM Sachs Adam David CEO Mar 04 '24 Sale 0.37 16,040 5,954 1,735,050 Mar 05 04:33 PM Kelly William John CFO and Treasurer Mar 04 '24 Sale 0.37 7,535 2,794 519,131 Mar 05 04:32 PM Sachs Adam David CEO Feb 20 '24 Sale 0.36 28,282 10,094 1,751,090 Feb 21 05:29 PM Khalifa Sammy Chief Technology Officer Feb 20 '24 Sale 0.36 22,625 8,242 1,228,113 Feb 21 05:28 PM Kelly William John CFO and Treasurer Feb 20 '24 Sale 0.36 7,555 2,753 526,666 Feb 21 05:28 PM Kelly William John CFO and Treasurer Nov 06 '23 Sale 0.45 4,984 2,219 534,221 Nov 08 03:33 PM Kelly William John CFO and Treasurer Oct 05 '23 Sale 0.49 4,858 2,367 539,205 Oct 06 01:11 PM Khalifa Sammy Chief Technology Officer Sep 20 '23 Sale 0.79 3,133 2,462 1,250,738 Sep 22 04:25 PM Kelly William John CFO and Treasurer Sep 20 '23 Sale 0.79 1,107 872 544,063 Sep 22 04:23 PM Morris June CLO, GC and Secretary Sep 20 '23 Sale 0.79 1,095 860 580,181 Sep 22 04:22 PM Sachs Adam David President and CEO Sep 20 '23 Sale 0.79 4,142 3,261 1,779,372 Sep 22 04:21 PM
Index S&P 500
P/E 27.50
EPS (ttm) 2.43
Insider Own 1.72%
Shs Outstand 601.10M
Perf Week -4.72%
Market Cap 40.25B
Forward P/E 23.57
EPS next Y 2.83
Insider Trans -1.79%
Shs Float 592.02M
Perf Month 9.40%
Income 1.47B
PEG 2.94
EPS next Q 0.68
Inst Own 85.50%
Short Float 1.07%
Perf Quarter -23.80%
Sales 6.00B
P/S 6.71
EPS this Y 8.16%
Inst Trans -0.08%
Short Ratio 1.19
Perf Half Y -28.78%
Book/sh 12.35
P/B 5.41
EPS next Y 4.41%
ROA 15.44%
Short Interest 6.34M
Perf Year -13.19%
Cash/sh 3.31
P/C 20.19
EPS next 5Y 9.34%
ROE 21.35%
52W Range 58.93 - 96.12
Perf YTD -12.38%
Dividend Est. -
P/FCF 70.39
EPS past 5Y 15.35%
ROI 18.17%
52W High -30.49%
Beta 1.14
Dividend TTM -
Quick Ratio 2.87
Sales past 5Y 10.28%
Gross Margin 76.52%
52W Low 13.37%
ATR (14) 2.25
Dividend Ex-Date -
Current Ratio 3.71
EPS Y/Y TTM 7.39%
Oper. Margin 27.21%
RSI (14) 41.06
Volatility 3.36% 2.76%
Employees 19800
Debt/Eq 0.09
Sales Y/Y TTM 6.05%
Profit Margin 24.55%
Recom 2.24
Target Price 80.36
Option/Short Yes / Yes
LT Debt/Eq 0.09
EPS Q/Q 20.47%
Payout 0.00%
Rel Volume 1.15
Prev Close 66.02
Sales Surprise -1.27%
EPS Surprise 0.82%
Sales Q/Q -9.43%
Earnings Jul 24 AMC
Avg Volume 5.34M
Price 66.81
SMA20 -2.04%
SMA50 -11.79%
SMA200 -17.95%
Trades
Volume 6,151,294
Change 1.20%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-31-24 Upgrade
Daiwa Securities
Neutral → Outperform
Jul-29-24 Upgrade
Wolfe Research
Underperform → Peer Perform
Jul-25-24 Downgrade
Truist
Buy → Hold
$110 → $82
Jul-25-24 Downgrade
TD Cowen
Buy → Hold
$100 → $70
Jul-25-24 Downgrade
Robert W. Baird
Outperform → Neutral
$102 → $70
Jul-25-24 Downgrade
JP Morgan
Overweight → Neutral
$105 → $72
Jul-25-24 Downgrade
BofA Securities
Buy → Neutral
$105 → $75
May-30-24 Initiated
Goldman
Buy
$107
May-22-24 Upgrade
Citigroup
Neutral → Buy
$98 → $105
May-14-24 Upgrade
Deutsche Bank
Hold → Buy
Mar-07-24 Upgrade
BofA Securities
Neutral → Buy
Feb-02-24 Upgrade
Wells Fargo
Equal Weight → Overweight
$94
Jan-04-24 Downgrade
Evercore ISI
Outperform → In-line
$80 → $77
Dec-11-23 Downgrade
Citigroup
Buy → Neutral
Nov-28-23 Downgrade
Wolfe Research
Peer Perform → Underperform
$57
Sep-26-23 Upgrade
Oppenheimer
Perform → Outperform
$90
Jul-19-23 Initiated
Robert W. Baird
Outperform
$107
May-30-23 Resumed
Morgan Stanley
Overweight
$102
Mar-29-23 Initiated
UBS
Neutral
$84
Mar-08-23 Downgrade
Wells Fargo
Overweight → Equal Weight
$97 → $78
Show Previous Ratings
Sep-05-24 05:30AM
Sep-04-24 11:28AM
(Design & Development Today)
Sep-03-24 04:30PM
Sep-02-24 04:12AM
Aug-31-24 06:58PM
12:35PM
Loading…
12:35PM
Aug-23-24 11:30AM
Aug-21-24 07:00AM
Aug-20-24 06:53AM
06:53AM
Aug-19-24 07:25AM
Aug-16-24 07:27AM
Aug-13-24 06:01PM
Jul-29-24 09:15AM
Jul-26-24 03:24AM
(The Wall Street Journal)
07:05PM
Loading…
Jul-25-24 07:05PM
(Morningstar Research) -31.34%
05:30PM
(The Wall Street Journal)
05:05PM
04:23PM
04:10PM
(Investor's Business Daily)
12:34PM
12:30PM
(The Wall Street Journal)
12:01PM
11:48AM
(The Wall Street Journal)
09:59AM
09:02AM
08:36AM
04:52AM
Jul-24-24 06:00PM
05:25PM
05:05PM
Loading…
05:05PM
(Investor's Business Daily)
04:34PM
(Investor's Business Daily)
04:24PM
(Associated Press Finance)
04:15PM
04:15PM
Jul-22-24 09:14AM
Jul-20-24 08:45PM
Jul-18-24 11:49AM
Jul-17-24 10:00AM
07:05AM
Jul-16-24 06:53AM
Jul-15-24 11:02AM
09:00AM
07:14AM
06:33AM
Jul-10-24 02:21PM
Jun-28-24 07:58AM
Jun-27-24 05:06AM
Jun-26-24 02:12PM
Jun-20-24 05:48AM
Jun-06-24 07:43AM
Jun-05-24 11:45AM
Jun-04-24 04:45AM
Jun-03-24 04:30PM
(Investor's Business Daily)
03:46PM
02:04PM
11:35AM
08:25AM
(The Wall Street Journal)
06:30AM
06:30AM
May-24-24 10:57AM
May-14-24 04:33PM
07:53AM
May-13-24 05:52PM
02:20PM
May-08-24 07:21PM
May-07-24 07:52AM
May-01-24 05:27PM
09:40AM
09:35AM
Apr-30-24 05:03PM
10:20AM
Apr-29-24 02:22PM
12:18PM
07:23AM
Apr-26-24 04:09PM
(Investor's Business Daily)
11:21AM
11:09AM
10:54AM
10:42AM
10:38AM
(Thomson Reuters StreetEvents)
10:29AM
09:53AM
08:28AM
03:40AM
Apr-25-24 06:00PM
05:52PM
05:30PM
05:04PM
(Investor's Business Daily)
04:34PM
04:26PM
(Associated Press Finance)
04:15PM
Apr-23-24 06:14AM
Apr-22-24 09:16AM
Apr-19-24 01:08AM
Apr-18-24 10:01AM
07:10AM
Apr-17-24 11:01AM
Apr-12-24 04:37AM
Apr-07-24 04:30PM
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Chopra Daveen CVP, TMTT Aug 20 '24 Sale 69.95 1,250 87,438 29,333 Aug 20 07:42 PM Chopra Daveen Officer Aug 20 '24 Proposed Sale 69.95 1,250 87,438 Aug 20 05:12 PM BOBO DONALD E JR CVP,Strategy/Corp Development Aug 14 '24 Option Exercise 45.28 5,000 226,384 51,936 Aug 14 05:58 PM BOBO DONALD E JR CVP,Strategy/Corp Development Aug 14 '24 Sale 66.08 5,000 330,420 46,936 Aug 14 05:58 PM BOBO DONALD E JR Officer Aug 14 '24 Proposed Sale 66.08 15,000 991,260 Aug 14 04:19 PM Lippis Daniel J. CVP, JAPAC Jul 11 '24 Option Exercise 45.28 500 22,638 23,689 Jul 11 05:38 PM Lippis Daniel J. CVP, JAPAC Jul 11 '24 Sale 94.18 500 47,090 23,189 Jul 11 05:38 PM BOBO DONALD E JR CVP,Strategy/Corp Development Jul 10 '24 Option Exercise 45.28 5,000 226,384 51,936 Jul 10 05:36 PM BOBO DONALD E JR CVP,Strategy/Corp Development Jul 10 '24 Sale 93.29 5,000 466,474 46,936 Jul 10 05:36 PM Lippis Daniel J. CVP, JAPAC Jun 20 '24 Option Exercise 45.28 535 24,223 24,048 Jun 20 05:44 PM Lippis Daniel J. CVP, JAPAC Jun 20 '24 Sale 90.00 535 48,150 23,513 Jun 20 05:44 PM Ullem Scott B. CVP, Chief Financial Officer Jun 20 '24 Option Exercise 45.28 5,625 254,681 36,186 Jun 20 05:43 PM Ullem Scott B. CVP, Chief Financial Officer Jun 20 '24 Sale 87.51 5,625 492,258 30,561 Jun 20 05:43 PM BOBO DONALD E JR CVP,Strategy/Corp Development Jun 12 '24 Option Exercise 45.28 5,000 226,384 51,936 Jun 12 05:19 PM BOBO DONALD E JR CVP,Strategy/Corp Development Jun 12 '24 Sale 87.54 5,000 437,696 46,936 Jun 12 05:19 PM Zovighian Bernard J CEO May 30 '24 Sale 87.68 8,617 755,539 68,218 May 30 05:10 PM Ullem Scott B. CVP, Chief Financial Officer May 21 '24 Option Exercise 45.28 5,625 254,681 36,186 May 21 05:09 PM Ullem Scott B. CVP, Chief Financial Officer May 21 '24 Sale 90.45 5,625 508,803 30,561 May 21 05:09 PM BOBO DONALD E JR CVP,Strategy/Corp Development May 10 '24 Option Exercise 45.28 5,000 226,384 52,750 May 13 05:45 PM BOBO DONALD E JR CVP,Strategy/Corp Development May 10 '24 Sale 87.81 5,000 439,038 47,750 May 13 05:45 PM Lippis Daniel J. CVP, JAPAC May 07 '24 Option Exercise 36.75 857 31,495 25,333 May 09 07:40 PM Lippis Daniel J. CVP, JAPAC May 07 '24 Sale 85.60 857 73,359 23,890 May 09 07:40 PM Zovighian Bernard J CEO May 04 '24 Option Exercise 0.00 6,265 0 50,554 May 07 05:53 PM Zovighian Bernard J CEO May 06 '24 Buy 85.74 580 49,753 3,268 May 07 05:53 PM Ullem Scott B. CVP, Chief Financial Officer May 04 '24 Option Exercise 0.00 7,465 0 25,905 May 06 07:18 PM Szyman Catherine M. CVP, Critical Care May 04 '24 Option Exercise 0.00 5,796 0 49,018 May 06 07:18 PM Lemercier Jean-Luc M CVP, EMEACLA and JAPAC May 04 '24 Option Exercise 0.00 4,157 0 177,969 May 06 07:18 PM Wood Larry L Global President TAVR & Surg May 04 '24 Option Exercise 0.00 6,675 0 220,022 May 06 07:17 PM Chopra Daveen CVP, TMTT May 04 '24 Option Exercise 0.00 4,713 0 27,172 May 06 07:17 PM BOBO DONALD E JR CVP,Strategy/Corp Development May 04 '24 Option Exercise 0.00 5,855 0 45,144 May 06 07:16 PM MUSSALLEM MICHAEL A Director May 02 '24 Option Exercise 36.75 29,350 1,078,612 33,836 May 02 06:05 PM MUSSALLEM MICHAEL A Director May 02 '24 Sale 84.77 29,350 2,487,966 4,486 May 02 06:05 PM Lemercier Jean-Luc M CVP, EMEACLA and JAPAC May 01 '24 Option Exercise 36.75 14,400 529,200 188,249 May 01 05:17 PM Lemercier Jean-Luc M CVP, EMEACLA and JAPAC May 01 '24 Sale 84.21 14,400 1,212,687 173,849 May 01 05:17 PM Ullem Scott B. CVP, Chief Financial Officer Apr 30 '24 Option Exercise 36.75 7,250 266,438 26,324 Apr 30 04:56 PM Ullem Scott B. CVP, Chief Financial Officer Apr 30 '24 Sale 85.80 7,250 622,062 19,074 Apr 30 04:56 PM Lippis Daniel J. CVP, JAPAC Apr 09 '24 Option Exercise 36.75 857 31,495 18,345 Apr 09 05:33 PM Lippis Daniel J. CVP, JAPAC Apr 09 '24 Sale 92.34 857 79,135 17,488 Apr 09 05:33 PM Lemercier Jean-Luc M CVP, EMEACLA Apr 08 '24 Option Exercise 36.75 14,400 529,200 188,249 Apr 08 05:10 PM Lemercier Jean-Luc M CVP, EMEACLA Apr 08 '24 Sale 92.32 14,400 1,329,472 173,849 Apr 08 05:10 PM BOBO DONALD E JR CVP,Strategy/Corp Development Apr 08 '24 Option Exercise 36.75 12,500 459,375 52,268 Apr 08 05:10 PM BOBO DONALD E JR CVP,Strategy/Corp Development Apr 08 '24 Sale 92.33 12,500 1,154,142 39,768 Apr 08 05:10 PM MUSSALLEM MICHAEL A Director Apr 04 '24 Option Exercise 36.75 29,350 1,078,612 33,836 Apr 04 06:26 PM MUSSALLEM MICHAEL A Director Apr 04 '24 Sale 92.42 29,350 2,712,418 4,486 Apr 04 06:26 PM Ullem Scott B. CVP, Chief Financial Officer Apr 01 '24 Option Exercise 36.75 7,255 266,621 26,329 Apr 01 06:55 PM Ullem Scott B. CVP, Chief Financial Officer Apr 01 '24 Sale 94.89 7,255 688,423 19,074 Apr 01 06:55 PM BOBO DONALD E JR CVP,Strategy/Corp Development Mar 13 '24 Option Exercise 36.75 14,500 532,875 54,003 Mar 13 05:44 PM BOBO DONALD E JR CVP,Strategy/Corp Development Mar 13 '24 Sale 91.01 14,500 1,319,696 39,503 Mar 13 05:44 PM Lemercier Jean-Luc M CVP, EMEACLA and JAPAC Mar 11 '24 Option Exercise 36.75 14,400 529,200 187,984 Mar 11 06:00 PM Lemercier Jean-Luc M CVP, EMEACLA and JAPAC Mar 11 '24 Sale 91.68 14,400 1,320,149 173,584 Mar 11 06:00 PM Lippis Daniel J. CVP, JAPAC Mar 07 '24 Option Exercise 36.75 1,715 63,026 18,928 Mar 07 06:22 PM Lippis Daniel J. CVP, JAPAC Mar 07 '24 Sale 90.98 1,715 156,031 17,213 Mar 07 06:22 PM MUSSALLEM MICHAEL A Director Mar 04 '24 Option Exercise 36.75 29,350 1,078,612 33,836 Mar 04 07:16 PM MUSSALLEM MICHAEL A Director Mar 04 '24 Sale 86.67 29,350 2,543,737 4,486 Mar 04 07:16 PM Ullem Scott B. CVP, Chief Financial Officer Feb 29 '24 Option Exercise 36.75 7,255 266,621 26,329 Feb 29 05:12 PM Ullem Scott B. CVP, Chief Financial Officer Feb 29 '24 Sale 85.59 7,255 620,923 19,074 Feb 29 05:12 PM GALLAHUE KIERAN Director Feb 23 '24 Option Exercise 36.86 7,056 260,107 10,757 Feb 26 05:52 PM GALLAHUE KIERAN Director Feb 23 '24 Sale 87.61 3,058 267,911 67,219 Feb 26 05:52 PM Chopra Daveen CVP, TMTT Feb 21 '24 Option Exercise 59.26 7,000 414,797 30,950 Feb 21 05:52 PM Chopra Daveen CVP, TMTT Feb 21 '24 Sale 86.74 8,200 711,272 22,750 Feb 21 05:52 PM Szyman Catherine M. CVP, Critical Care Feb 15 '24 Option Exercise 36.75 27,000 992,250 61,814 Feb 15 05:25 PM Szyman Catherine M. CVP, Critical Care Feb 13 '24 Option Exercise 36.75 20,000 735,000 54,814 Feb 15 05:25 PM Szyman Catherine M. CVP, Critical Care Feb 15 '24 Sale 85.62 27,000 2,311,654 34,814 Feb 15 05:25 PM Szyman Catherine M. CVP, Critical Care Feb 13 '24 Sale 86.46 20,000 1,729,200 34,814 Feb 15 05:25 PM BOBO DONALD E JR CVP,Strategy/Corp Development Feb 13 '24 Option Exercise 36.75 11,000 404,250 50,503 Feb 13 04:51 PM BOBO DONALD E JR CVP,Strategy/Corp Development Feb 13 '24 Sale 85.83 11,000 944,155 39,503 Feb 13 04:51 PM SELLERS ROBERT W.A. SVP, Corporate Controller Feb 12 '24 Option Exercise 36.75 12,210 448,718 25,297 Feb 12 05:44 PM SELLERS ROBERT W.A. SVP, Corporate Controller Feb 12 '24 Sale 87.00 12,210 1,062,270 13,087 Feb 12 05:44 PM STONE HEISZ LESLIE Director Feb 08 '24 Option Exercise 36.86 7,056 260,107 34,036 Feb 08 06:08 PM STONE HEISZ LESLIE Director Feb 08 '24 Sale 86.45 7,056 609,991 26,980 Feb 08 06:08 PM MUSSALLEM MICHAEL A Director Feb 05 '24 Option Exercise 36.75 29,350 1,078,612 33,836 Feb 05 06:37 PM MUSSALLEM MICHAEL A Director Feb 05 '24 Sale 87.49 29,350 2,567,754 4,486 Feb 05 06:37 PM Ullem Scott B. CVP, Chief Financial Officer Feb 01 '24 Option Exercise 36.75 7,255 266,621 26,503 Feb 01 05:52 PM Ullem Scott B. CVP, Chief Financial Officer Feb 01 '24 Sale 78.29 7,255 567,994 19,248 Feb 01 05:52 PM BOBO DONALD E JR CVP,Strategy/Corp Development Jan 12 '24 Option Exercise 36.75 10,000 367,500 49,503 Jan 12 05:36 PM BOBO DONALD E JR CVP,Strategy/Corp Development Jan 12 '24 Sale 75.67 10,000 756,700 39,503 Jan 12 05:36 PM MUSSALLEM MICHAEL A Director Jan 05 '24 Option Exercise 36.75 29,350 1,078,612 33,836 Jan 05 07:19 PM MUSSALLEM MICHAEL A Director Jan 05 '24 Sale 72.98 29,350 2,142,089 4,486 Jan 05 07:19 PM Ullem Scott B. CVP, Chief Financial Officer Dec 29 '23 Option Exercise 36.75 14,510 533,242 33,758 Dec 29 04:25 PM Ullem Scott B. CVP, Chief Financial Officer Dec 29 '23 Sale 76.55 14,510 1,110,794 19,248 Dec 29 04:25 PM Chopra Daveen CVP, TMTT Dec 15 '23 Option Exercise 59.26 7,000 414,797 30,950 Dec 15 05:22 PM Chopra Daveen CVP, TMTT Dec 15 '23 Sale 78.25 7,000 547,724 23,950 Dec 15 05:22 PM BOBO DONALD E JR CVP,Strategy/Corp Development Dec 13 '23 Option Exercise 36.75 8,000 294,000 47,503 Dec 13 07:04 PM BOBO DONALD E JR CVP,Strategy/Corp Development Dec 13 '23 Sale 71.86 8,000 574,880 39,503 Dec 13 07:04 PM Wood Larry L Global President TAVR & Surg Dec 13 '23 Option Exercise 45.28 8,658 392,006 222,452 Dec 13 07:04 PM Wood Larry L Global President TAVR & Surg Dec 13 '23 Sale 71.86 8,658 622,164 213,794 Dec 13 07:04 PM MUSSALLEM MICHAEL A Director Dec 13 '23 Option Exercise 36.75 29,350 1,078,612 33,836 Dec 13 07:04 PM MUSSALLEM MICHAEL A Director Dec 13 '23 Sale 74.62 29,350 2,190,043 4,486 Dec 13 07:04 PM Chopra Daveen CVP, TMTT Dec 06 '23 Option Exercise 59.26 3,500 207,398 27,450 Dec 06 05:01 PM Chopra Daveen CVP, TMTT Dec 06 '23 Sale 70.00 3,500 245,006 23,950 Dec 06 05:01 PM Wood Larry L Global President TAVR & Surg Nov 13 '23 Option Exercise 45.28 8,660 392,096 222,454 Nov 13 05:21 PM Wood Larry L Global President TAVR & Surg Nov 13 '23 Sale 65.30 8,660 565,460 213,794 Nov 13 05:21 PM BOBO DONALD E JR CVP,Strategy/Corp Development Nov 13 '23 Option Exercise 36.75 6,000 220,500 45,503 Nov 13 05:21 PM BOBO DONALD E JR CVP,Strategy/Corp Development Nov 13 '23 Sale 65.30 6,000 391,780 39,503 Nov 13 05:21 PM MUSSALLEM MICHAEL A Director Nov 03 '23 Option Exercise 36.75 29,350 1,078,612 33,836 Nov 06 06:33 PM MUSSALLEM MICHAEL A Director Nov 03 '23 Sale 67.18 29,350 1,971,733 4,486 Nov 06 06:33 PM Ullem Scott B. CVP, Chief Financial Officer Oct 31 '23 Option Exercise 36.75 7,255 266,621 26,503 Oct 31 05:22 PM Ullem Scott B. CVP, Chief Financial Officer Oct 31 '23 Sale 62.66 7,255 454,569 19,248 Oct 31 05:22 PM Wood Larry L Global President TAVR & Surg Oct 13 '23 Option Exercise 45.28 8,660 392,096 222,454 Oct 13 05:02 PM Wood Larry L Global President TAVR & Surg Oct 13 '23 Sale 70.00 8,660 606,198 213,794 Oct 13 05:02 PM
Index -
P/E -
EPS (ttm) -3.11
Insider Own 11.83%
Shs Outstand 26.09M
Perf Week -6.58%
Market Cap 1.07B
Forward P/E -
EPS next Y -1.15
Insider Trans -0.49%
Shs Float 22.75M
Perf Month 16.96%
Income -83.20M
PEG -
EPS next Q -0.60
Inst Own 92.19%
Short Float 20.86%
Perf Quarter -19.63%
Sales 151.35M
P/S 7.09
EPS this Y 26.46%
Inst Trans 0.09%
Short Ratio 14.87
Perf Half Y -16.65%
Book/sh 1.61
P/B 25.81
EPS next Y 49.04%
ROA -29.17%
Short Interest 4.75M
Perf Year -27.62%
Cash/sh 2.12
P/C 19.66
EPS next 5Y -
ROE -166.58%
52W Range 16.96 - 60.12
Perf YTD 60.64%
Dividend Est. -
P/FCF -
EPS past 5Y -20.32%
ROI -34.42%
52W High -30.82%
Beta 1.22
Dividend TTM -
Quick Ratio 2.90
Sales past 5Y 24.05%
Gross Margin 66.04%
52W Low 145.22%
ATR (14) 2.28
Dividend Ex-Date -
Current Ratio 4.44
EPS Y/Y TTM -26.87%
Oper. Margin -40.52%
RSI (14) 44.06
Volatility 5.12% 5.16%
Employees 908
Debt/Eq 4.39
Sales Y/Y TTM -14.56%
Profit Margin -54.97%
Recom 1.29
Target Price 60.43
Option/Short Yes / Yes
LT Debt/Eq 4.37
EPS Q/Q 5.81%
Payout -
Rel Volume 0.29
Prev Close 42.50
Sales Surprise 2.36%
EPS Surprise -20.83%
Sales Q/Q -9.15%
Earnings Aug 06 AMC
Avg Volume 319.18K
Price 41.59
SMA20 -4.08%
SMA50 -5.18%
SMA200 -1.12%
Trades
Volume 92,948
Change -2.14%
Date
Action
Analyst
Rating Change
Price Target Change
May-22-24 Downgrade
Citigroup
Buy → Neutral
$60
Aug-31-23 Initiated
JP Morgan
Overweight
$75
Jun-29-23 Initiated
Citigroup
Buy
$79
Oct-14-22 Resumed
Stephens
Overweight
$90
Oct-13-22 Initiated
Mizuho
Buy
$70
Aug-24-22 Initiated
B. Riley Securities
Buy
$107
Aug-27-20 Initiated
UBS
Buy
$23
May-14-20 Initiated
Goldman
Neutral
$20
Feb-06-20 Initiated
BTIG Research
Buy
$40
Jun-28-19 Initiated
Wells Fargo
Outperform
$29
Jun-07-19 Initiated
Stephens
Overweight
$37
Show Previous Ratings
Aug-26-24 06:18AM
Aug-09-24 06:43AM
Aug-06-24 05:15PM
04:00PM
Jul-24-24 08:00AM
04:33AM
Loading…
Jun-25-24 04:33AM
Jun-17-24 07:39AM
May-23-24 08:00AM
May-10-24 05:29PM
01:37PM
May-09-24 06:50AM
(Thomson Reuters StreetEvents) +10.89%
May-08-24 09:00PM
05:10PM
04:00PM
May-02-24 08:30AM
08:30AM
Loading…
May-01-24 08:30AM
Apr-24-24 08:30AM
Apr-17-24 08:30AM
Feb-29-24 10:06AM
Feb-28-24 05:30PM
04:55PM
04:00PM
07:39AM
Feb-23-24 08:00AM
Feb-22-24 08:00AM
Feb-21-24 10:00AM
Feb-14-24 08:00AM
Feb-07-24 04:42AM
Jan-22-24 08:00AM
Jan-09-24 08:06AM
08:00AM
Loading…
Jan-02-24 08:00AM
Dec-28-23 08:30AM
Nov-10-23 08:00AM
Nov-09-23 08:00AM
Nov-08-23 04:42PM
11:38AM
Nov-07-23 05:25PM
05:11PM
04:00PM
Nov-02-23 09:05AM
Oct-31-23 10:01AM
Oct-25-23 08:00AM
Oct-17-23 08:42AM
Oct-16-23 06:00AM
Oct-13-23 08:00AM
Oct-02-23 07:36PM
(GuruFocus.com) -7.50%
-6.28%
Sep-11-23 01:01PM
Aug-08-23 05:15PM
04:00PM
Jul-29-23 11:30AM
Jul-26-23 08:00AM
Jul-24-23 08:43AM
Jul-19-23 08:00AM
May-31-23 08:00AM
May-30-23 08:00AM
May-09-23 06:48AM
(Thomson Reuters StreetEvents)
May-08-23 05:15PM
04:00PM
08:03AM
May-02-23 10:01AM
May-01-23 10:00AM
Apr-27-23 10:30AM
Apr-26-23 08:00AM
Apr-24-23 11:46PM
04:44PM
04:41PM
Apr-20-23 03:25PM
Apr-11-23 07:05AM
Apr-10-23 04:30PM
Apr-04-23 09:00AM
Apr-03-23 08:00AM
Mar-29-23 08:00AM
Mar-23-23 03:24PM
08:00AM
Mar-11-23 03:41AM
Mar-01-23 05:39AM
Feb-28-23 08:00AM
Feb-27-23 04:00PM
09:55AM
Feb-14-23 06:28AM
Feb-13-23 08:00AM
Feb-09-23 09:55AM
Jan-09-23 08:00AM
Jan-03-23 08:03AM
Dec-31-22 06:15AM
Dec-28-22 08:00AM
Nov-10-22 08:00AM
Nov-07-22 05:15PM
04:00PM
Nov-04-22 11:27AM
Nov-01-22 10:01AM
08:00AM
Oct-31-22 10:01AM
Oct-24-22 08:00AM
Oct-19-22 09:22AM
Oct-08-22 09:53AM
Sep-20-22 04:30PM
Sep-12-22 08:00AM
Sep-07-22 06:31AM
Aug-11-22 06:19AM
Establishment Labs Holdings, Inc. is a technology company, which engages in the design, development, manufacture, and marketing of silicone breast implants. It generates income from customers in Europe, the Middle East, Latin America, and Asia. The firm's products include Motiva Implants, Motiva Flora Tissue Expander, Motiva Ergonomix, and Motiva Ergonomix2. The company was founded by Juan Jose Chacon-Quiros in 2004 and is headquartered in Alajuela, Costa Rica.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Chacon Quiros Juan Jose Chief Executive Officer Jul 11 '24 Sale 45.04 3,641 163,989 210,735 Jul 11 04:38 PM Chacon Quiros Juan Jose Chief Executive Officer Jul 08 '24 Sale 45.01 3,866 174,012 215,030 Jul 10 05:33 PM Chacon Quiros Juan Jose Chief Executive Officer Jul 09 '24 Sale 45.00 654 29,431 214,376 Jul 10 05:33 PM Chacon Quiros Juan Jose Chief Executive Officer Jul 01 '24 Sale 45.30 6,839 309,775 218,896 Jul 03 02:31 PM LEWIN NICHOLAS SHERIDAN Director Dec 14 '23 Buy 27.04 2,000 54,073 1,064,888 Dec 15 07:59 AM LEWIN NICHOLAS SHERIDAN Director Nov 20 '23 Buy 22.00 5,000 110,000 14,190 Nov 21 08:00 AM Denhoy Raj Chief Financial Officer Nov 17 '23 Buy 22.21 2,250 49,972 8,112 Nov 20 08:00 AM LEWIN NICHOLAS SHERIDAN Director Nov 13 '23 Option Exercise 18.00 250,000 4,500,000 1,062,888 Nov 15 08:01 AM
Index -
P/E -
EPS (ttm) -2.77
Insider Own 20.99%
Shs Outstand 8.59M
Perf Week -8.04%
Market Cap 27.10M
Forward P/E -
EPS next Y -0.94
Insider Trans -0.16%
Shs Float 6.93M
Perf Month -15.80%
Income -23.75M
PEG -
EPS next Q -0.32
Inst Own 5.16%
Short Float 2.82%
Perf Quarter -32.68%
Sales 23.28M
P/S 1.16
EPS this Y 33.20%
Inst Trans -30.90%
Short Ratio 5.80
Perf Half Y -40.91%
Book/sh 4.25
P/B 0.73
EPS next Y 45.38%
ROA -40.67%
Short Interest 0.20M
Perf Year -36.02%
Cash/sh 1.73
P/C 1.79
EPS next 5Y -
ROE -49.65%
52W Range 3.00 - 9.10
Perf YTD -43.24%
Dividend Est. -
P/FCF -
EPS past 5Y 52.11%
ROI -64.52%
52W High -66.04%
Beta 2.03
Dividend TTM -
Quick Ratio 2.25
Sales past 5Y 28.83%
Gross Margin 24.74%
52W Low 2.99%
ATR (14) 0.24
Dividend Ex-Date -
Current Ratio 2.97
EPS Y/Y TTM -22.23%
Oper. Margin -104.63%
RSI (14) 36.38
Volatility 5.22% 7.92%
Employees 108
Debt/Eq 0.04
Sales Y/Y TTM 313.30%
Profit Margin -102.03%
Recom 1.00
Target Price 10.75
Option/Short Yes / Yes
LT Debt/Eq 0.00
EPS Q/Q 8.42%
Payout -
Rel Volume 0.75
Prev Close 3.23
Sales Surprise 0.86%
EPS Surprise 9.09%
Sales Q/Q 401.65%
Earnings Aug 15 BMO
Avg Volume 33.75K
Price 3.09
SMA20 -10.81%
SMA50 -17.56%
SMA200 -38.54%
Trades
Volume 25,145
Change -4.33%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-03-17 Downgrade
Barclays
Equal Weight → Underweight
$2.50 → $1.50
Dec-16-16 Initiated
Oppenheimer
Outperform
Jul-15-16 Initiated
Piper Jaffray
Overweight
$10
May-22-15 Upgrade
Canaccord Genuity
Hold → Buy
$11 → $17
May-08-15 Reiterated
Barclays
Equal Weight
$20 → $13
Oct-07-14 Initiated
Barclays
Equal Weight
$28
Sep-05-24 08:30AM
Sep-04-24 04:15PM
Aug-15-24 08:00AM
Aug-08-24 04:15PM
Jul-02-24 04:30PM
08:30AM
Loading…
Jun-26-24 08:30AM
Jun-11-24 10:50AM
Jun-04-24 04:30PM
May-28-24 03:32AM
May-16-24 08:18AM
May-15-24 09:10AM
08:00AM
May-14-24 12:00PM
May-07-24 04:30PM
May-02-24 10:01AM
10:19AM
Loading…
Apr-26-24 10:19AM
Apr-23-24 09:55AM
Apr-19-24 08:30AM
Apr-12-24 08:30AM
Apr-01-24 04:30PM
Mar-24-24 03:54PM
Mar-22-24 08:30AM
Mar-13-24 11:45AM
Mar-08-24 08:30AM
Mar-01-24 12:00PM
08:45AM
Feb-27-24 09:15AM
08:00AM
Feb-20-24 08:30AM
Jan-29-24 08:00AM
08:07PM
Loading…
Jan-28-24 08:07PM
Jan-16-24 08:47AM
Jan-12-24 08:30AM
Jan-11-24 05:00PM
Jan-05-24 08:00AM
Jan-04-24 08:00AM
Nov-30-23 04:45PM
(GlobeNewswire) +5.38%
-5.24%
Nov-28-23 07:33PM
08:00AM
Nov-20-23 09:20AM
Nov-14-23 08:15AM
(Associated Press Finance)
08:06AM
Nov-10-23 08:30AM
Nov-07-23 08:00AM
07:40AM
Nov-06-23 08:00AM
Nov-02-23 08:00AM
Oct-31-23 09:25AM
Oct-18-23 08:30AM
Sep-20-23 08:00AM
Sep-06-23 08:00AM
Sep-05-23 08:30AM
Aug-11-23 04:15PM
09:15AM
08:13AM
(Associated Press Finance)
08:00AM
Aug-09-23 12:46PM
(American City Business Journals)
Aug-08-23 04:15PM
Aug-03-23 04:15PM
Jul-28-23 04:15PM
Jul-11-23 05:30PM
07:00AM
Jul-07-23 08:30AM
Jul-05-23 08:30AM
Jun-30-23 04:58PM
(GlobeNewswire) +5.23%
+16.67%
Jun-28-23 11:47AM
May-11-23 09:15AM
08:06AM
08:00AM
May-10-23 05:35PM
May-09-23 07:15AM
May-04-23 06:25PM
08:30AM
May-03-23 04:30PM
08:30AM
Mar-07-23 08:00AM
Feb-26-23 07:24AM
Feb-23-23 09:45AM
08:00AM
Feb-16-23 08:00AM
Jan-19-23 07:24AM
Jan-05-23 08:30AM
Dec-22-22 08:00AM
Nov-23-22 10:00AM
Nov-11-22 08:00AM
Nov-07-22 09:15AM
08:00AM
Oct-31-22 04:15PM
Sep-28-22 07:15AM
Sep-12-22 08:00AM
Sep-08-22 08:30AM
Aug-12-22 07:54AM
Aug-09-22 09:15AM
08:00AM
Aug-03-22 08:00AM
Aug-02-22 04:30PM
Jul-21-22 08:00AM
Jun-23-22 08:00AM
Jun-10-22 04:15PM
Jun-02-22 08:00AM
ReWalk Robotics Ltd. Is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. Its products include ReWalk Exo-Suit and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Yokneam Ilit, Israel.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Lynch Jeannine VP of Market Access & Strategy Sep 03 '24 Sale 3.30 1,625 5,358 47,658 Sep 04 07:37 PM Jasinski Lawrence J Chief Executive Officer Aug 02 '24 Sale 3.84 2,665 10,234 103,309 Aug 06 09:07 AM Lynch Jeannine VP of Market Access & Strategy Aug 02 '24 Sale 3.84 1,783 6,847 49,283 Aug 06 09:07 AM Jasinski Lawrence J Officer Aug 02 '24 Proposed Sale 4.42 2,665 11,782 Aug 05 06:20 AM Lynch Jeannine VP of Market Access & Strategy Jul 01 '24 Sale 3.83 1,834 7,018 51,066 Jul 02 05:02 PM Jasinski Lawrence J Chief Executive Officer Jun 18 '24 Sale 4.22 3,466 14,617 105,974 Jun 21 08:47 AM Lawless Michael A Chief Financial Officer May 23 '24 Buy 4.97 2,000 9,940 4,150 May 28 04:42 PM Turk Joseph E Jr Director May 23 '24 Buy 5.01 7,916 39,659 12,516 May 24 08:17 PM Turk Joseph E Jr Director May 22 '24 Buy 5.01 84 421 4,600 May 24 08:17 PM Jasinski Lawrence J Chief Executive Officer May 21 '24 Sale 4.91 1,620 7,954 109,440 May 23 08:24 PM Lind Global Fund II LP 10% Owner Nov 17 '23 Buy 0.73 42,917 31,329 10,005,745 Nov 21 04:37 PM Lind Global Fund II LP 10% Owner Nov 20 '23 Buy 0.73 12,000 8,760 10,017,745 Nov 21 04:37 PM Lind Global Fund II LP 10% Owner Nov 14 '23 Buy 0.68 72,818 49,516 9,962,828 Nov 16 04:37 PM Lind Global Fund II LP 10% Owner Sep 26 '23 Buy 0.70 5,031,200 3,521,840 9,890,010 Sep 28 04:30 PM Lind Global Fund II LP 10% Owner Sep 26 '23 Sale 0.70 5,031,200 3,521,840 0 Sep 28 04:30 PM
Index -
P/E 88.11
EPS (ttm) 0.24
Insider Own 5.12%
Shs Outstand 7.36M
Perf Week -10.04%
Market Cap 158.43M
Forward P/E 11.67
EPS next Y 1.83
Insider Trans 0.55%
Shs Float 7.02M
Perf Month -2.90%
Income 1.92M
PEG 4.41
EPS next Q 0.38
Inst Own 68.68%
Short Float 1.75%
Perf Quarter -2.90%
Sales 137.74M
P/S 1.15
EPS this Y 22.92%
Inst Trans -7.03%
Short Ratio 2.32
Perf Half Y 29.05%
Book/sh 16.86
P/B 1.27
EPS next Y 107.34%
ROA 1.11%
Short Interest 0.12M
Perf Year 54.36%
Cash/sh 3.36
P/C 6.37
EPS next 5Y 20.00%
ROE 1.56%
52W Range 13.86 - 26.10
Perf YTD 15.48%
Dividend Est. -
P/FCF 138.98
EPS past 5Y 32.14%
ROI 1.16%
52W High -17.97%
Beta 0.59
Dividend TTM 0.12 (0.56%)
Quick Ratio 2.00
Sales past 5Y 7.33%
Gross Margin 40.65%
52W Low 54.47%
ATR (14) 0.95
Dividend Ex-Date Aug 15, 2024
Current Ratio 4.24
EPS Y/Y TTM -64.58%
Oper. Margin 1.25%
RSI (14) 33.05
Volatility 3.15% 3.22%
Employees 1750
Debt/Eq 0.35
Sales Y/Y TTM 15.60%
Profit Margin 1.39%
Recom 1.00
Target Price 27.00
Option/Short Yes / Yes
LT Debt/Eq 0.33
EPS Q/Q -157.35%
Payout 16.68%
Rel Volume 1.04
Prev Close 21.92
Sales Surprise -3.48%
EPS Surprise -137.21%
Sales Q/Q 16.45%
Earnings Sep 04 BMO
Avg Volume 53.07K
Price 21.41
SMA20 -9.76%
SMA50 -7.74%
SMA200 13.00%
Trades
Volume 55,388
Change -2.33%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-24-24 Initiated
Maxim Group
Buy
$22
Jun-09-20 Initiated
The Benchmark Company
Buy
Apr-15-20 Resumed
ROTH Capital
Buy
$18.50
Aug-23-17 Initiated
ROTH Capital
Buy
$18
Feb-10-16 Initiated
Singular Research
Buy
$17.50
Apr-13-07 Reiterated
Friedman Billings
Mkt Perform
$16 → $14
Sep-06-24 05:00AM
(Thomson Reuters StreetEvents)
Sep-04-24 05:45PM
04:43PM
(Associated Press Finance)
04:35PM
09:05AM
09:04AM
Loading…
Sep-03-24 09:04AM
Aug-22-24 10:33AM
09:40AM
Aug-21-24 04:15PM
Aug-14-24 06:22PM
Aug-06-24 09:40AM
Aug-01-24 04:55PM
04:15PM
Jul-18-24 04:11AM
Jul-12-24 04:15PM
08:40AM
Loading…
Jul-05-24 08:40AM
Jul-01-24 05:00PM
(ACCESSWIRE) -8.15%
+6.26%
Jun-17-24 04:45PM
Jun-12-24 09:40AM
Jun-10-24 08:50AM
Jun-06-24 08:02AM
Jun-05-24 11:52AM
Jun-04-24 09:52PM
06:05PM
05:02PM
(Associated Press Finance)
04:53PM
May-27-24 09:40AM
May-23-24 08:50AM
May-22-24 10:50AM
May-20-24 04:53PM
04:05PM
Loading…
04:05PM
May-07-24 03:01PM
03:01PM
May-03-24 09:40AM
May-01-24 04:30PM
04:05PM
Apr-29-24 04:55PM
09:00AM
Apr-12-24 12:29PM
02:11AM
(Thomson Reuters StreetEvents)
Apr-11-24 07:52AM
05:05AM
(Associated Press Finance)
Apr-10-24 10:05PM
Apr-08-24 10:39AM
Apr-02-24 05:15PM
Mar-28-24 11:55AM
Mar-12-24 08:15AM
Mar-07-24 08:30AM
Mar-05-24 12:46PM
Feb-15-24 04:04PM
Feb-14-24 02:45AM
Feb-06-24 05:03AM
Feb-05-24 04:15PM
Feb-01-24 04:15PM
Jan-30-24 08:50AM
Jan-24-24 01:34AM
Jan-11-24 12:45PM
Jan-08-24 09:29AM
Dec-25-23 08:50AM
Dec-15-23 12:00PM
Dec-08-23 09:07AM
01:32AM
(Thomson Reuters StreetEvents)
Dec-07-23 07:46AM
Dec-06-23 07:35PM
06:32PM
(Associated Press Finance)
06:25PM
Nov-30-23 04:05PM
Nov-22-23 08:15AM
Nov-14-23 08:55AM
Nov-13-23 04:05PM
Nov-01-23 04:05PM
Oct-24-23 10:15AM
Oct-19-23 04:05PM
Oct-18-23 08:50AM
Oct-11-23 07:29AM
Oct-10-23 10:49AM
Oct-04-23 08:24AM
Sep-27-23 08:50AM
Sep-11-23 12:00PM
08:50AM
Sep-08-23 08:13AM
Sep-07-23 09:56PM
(Thomson Reuters StreetEvents) +11.54%
Sep-06-23 06:15PM
05:13PM
05:00PM
Aug-28-23 08:30AM
Aug-21-23 04:15PM
Aug-12-23 09:43AM
Aug-01-23 04:05PM
Jul-25-23 12:00PM
Jul-21-23 05:00AM
Jul-20-23 10:35AM
Jul-06-23 12:45PM
Jun-29-23 07:06PM
Jun-20-23 12:45PM
Jun-12-23 03:46PM
Jun-09-23 06:03AM
Jun-08-23 10:02PM
(Thomson Reuters StreetEvents) +6.11%
Jun-07-23 04:36PM
04:30PM
Lakeland Industries, Inc. engages in the manufacture and sale of safety garments and accessories for the industrial and public protective clothing market. It operates through the Domestic and International geographical segments. The firm's products include disposable protective clothing, chemical protective clothing, woven protective clothing, fire protective gear, heat protective clothing, reflective protective clothing, hand and arm protection, arc or fire-retardant rated rainwear, and fire-retardant protective clothing. The company was founded in April 1982 and is headquartered in Huntsville, AL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Jenkins James M. President, CEO & Exec. Chair Jun 10 '24 Buy 23.98 2,085 49,998 75,728 Jun 12 03:17 PM
Index RUT
P/E 32.84
EPS (ttm) 1.03
Insider Own 36.24%
Shs Outstand 37.59M
Perf Week -6.21%
Market Cap 1.37B
Forward P/E 25.21
EPS next Y 1.34
Insider Trans -9.46%
Shs Float 25.89M
Perf Month 3.36%
Income 40.14M
PEG 2.03
EPS next Q 0.09
Inst Own 61.73%
Short Float 6.16%
Perf Quarter 4.96%
Sales 531.87M
P/S 2.58
EPS this Y 2.21%
Inst Trans -3.66%
Short Ratio 7.34
Perf Half Y -11.85%
Book/sh 7.37
P/B 4.59
EPS next Y 28.78%
ROA 7.87%
Short Interest 1.59M
Perf Year 31.32%
Cash/sh 2.61
P/C 12.98
EPS next 5Y 16.20%
ROE 16.73%
52W Range 25.15 - 39.81
Perf YTD 2.89%
Dividend Est. 0.35 (1.03%)
P/FCF 27.20
EPS past 5Y -
ROI 7.97%
52W High -14.99%
Beta 1.29
Dividend TTM 0.34 (1.01%)
Quick Ratio 2.14
Sales past 5Y 3.58%
Gross Margin 40.07%
52W Low 34.55%
ATR (14) 1.00
Dividend Ex-Date Aug 02, 2024
Current Ratio 3.17
EPS Y/Y TTM 31.97%
Oper. Margin 12.40%
RSI (14) 40.64
Volatility 2.90% 2.68%
Employees 2435
Debt/Eq 0.74
Sales Y/Y TTM 13.64%
Profit Margin 7.55%
Recom 1.50
Target Price 41.43
Option/Short Yes / Yes
LT Debt/Eq 0.68
EPS Q/Q 5.92%
Payout 31.40%
Rel Volume 0.50
Prev Close 35.19
Sales Surprise 1.58%
EPS Surprise 15.41%
Sales Q/Q 19.18%
Earnings Aug 09 AMC
Avg Volume 217.15K
Price 33.84
SMA20 -3.33%
SMA50 -4.16%
SMA200 -0.52%
Trades
Volume 107,673
Change -3.84%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-21-24 Reiterated
ROTH MKM
Buy
$32 → $38
Jan-22-24 Downgrade
Raymond James
Outperform → Mkt Perform
Sep-06-22 Initiated
BofA Securities
Buy
$30
Aug-31-22 Initiated
Jefferies
Buy
$32
Aug-09-24 08:52PM
05:30PM
04:39PM
04:15PM
Aug-08-24 03:02AM
04:15PM
Loading…
Aug-05-24 04:15PM
Jul-23-24 04:15PM
Jul-16-24 03:09AM
Jun-04-24 04:15PM
May-25-24 06:15AM
May-16-24 04:15PM
May-08-24 11:15AM
07:03AM
(Thomson Reuters StreetEvents)
04:21AM
May-07-24 06:10PM
05:44PM
Loading…
05:44PM
04:15PM
Apr-30-24 10:01AM
Apr-23-24 04:16PM
04:15PM
Mar-27-24 08:30AM
Mar-14-24 06:40PM
Mar-13-24 04:15PM
Mar-11-24 12:00PM
Mar-08-24 12:20PM
Mar-07-24 01:22PM
11:11AM
Mar-06-24 12:00PM
07:29AM
(Thomson Reuters StreetEvents)
Mar-05-24 05:30PM
04:15PM
Loading…
04:15PM
Mar-04-24 08:30AM
Feb-22-24 04:15PM
Feb-20-24 06:00AM
Feb-19-24 12:10PM
Jan-23-24 04:15PM
Jan-10-24 04:15PM
Jan-03-24 04:15PM
Dec-22-23 04:15PM
Dec-19-23 11:11AM
Dec-14-23 01:05AM
Nov-14-23 01:56PM
Nov-10-23 09:15AM
Nov-08-23 04:15PM
Oct-31-23 04:15PM
Oct-25-23 04:15PM
Oct-24-23 04:15PM
Oct-18-23 12:00PM
Oct-16-23 09:40AM
Sep-29-23 09:40AM
Sep-05-23 09:40AM
Aug-28-23 04:15PM
Aug-18-23 09:55AM
Aug-15-23 06:27AM
Aug-08-23 06:40PM
05:11PM
Aug-07-23 07:41AM
Jul-29-23 08:08AM
Jul-25-23 04:16PM
04:15PM
Jul-04-23 08:24PM
Jun-28-23 06:20AM
Jun-05-23 09:51PM
04:28PM
May-13-23 08:15AM
May-09-23 07:05PM
04:15PM
May-01-23 06:35PM
Apr-29-23 08:03AM
Apr-25-23 04:16PM
04:15PM
Apr-13-23 10:30AM
Mar-19-23 11:15PM
Mar-17-23 02:08PM
Mar-16-23 09:12AM
(Thomson Reuters StreetEvents)
Mar-15-23 05:45PM
04:15PM
Mar-08-23 04:15PM
Mar-01-23 06:05PM
04:15PM
Feb-28-23 08:35AM
Feb-21-23 05:08AM
Feb-09-23 04:01PM
Feb-08-23 08:55AM
Jan-28-23 07:42AM
Jan-24-23 04:15PM
Jan-01-23 07:17AM
Dec-28-22 11:58AM
Dec-04-22 07:54AM
Nov-10-22 06:15PM
04:15PM
Nov-09-22 06:35PM
Nov-08-22 06:55PM
Nov-07-22 09:15AM
Nov-04-22 10:21AM
Nov-02-22 04:15PM
Oct-31-22 08:53AM
Oct-27-22 04:15PM
Oct-20-22 04:15PM
Aug-29-22 01:09PM
Cadre Holdings, Inc. engages in the manufacture and distribution of safety and survivability products, and other related products for the law enforcement, first responder and military markets. It operates through the Product and Distribution segments. It sells a wide range of products including body armor, explosive ordnance disposal equipment and duty gear through both direct and indirect channels. The company was founded on April 12, 2012 and is headquartered in Jacksonville, FL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
SOKOLOW NICOLAS Director Aug 20 '24 Sale 35.10 20,000 702,030 487,620 Aug 21 04:15 PM Nicolas Sokolow Director Aug 20 '24 Proposed Sale 35.03 20,000 700,600 Aug 20 01:04 PM SOKOLOW NICOLAS Director Aug 15 '24 Sale 33.81 25,000 845,250 507,620 Aug 16 04:15 PM SOKOLOW NICOLAS Director Aug 14 '24 Sale 33.68 15,000 505,136 532,620 Aug 16 04:15 PM Nicolas Sokolow Director Aug 14 '24 Proposed Sale 33.91 40,000 1,356,400 Aug 13 04:17 PM SOKOLOW NICOLAS Director Jun 07 '24 Sale 32.08 8,596 275,717 547,620 Jun 10 04:15 PM SOKOLOW NICOLAS Director Jun 05 '24 Sale 32.66 20,000 653,200 557,620 Jun 07 04:15 PM SOKOLOW NICOLAS Director Jun 06 '24 Sale 32.77 1,404 46,004 556,216 Jun 07 04:15 PM SOKOLOW NICOLAS Director Jun 03 '24 Sale 32.29 10,000 322,912 577,620 Jun 05 04:15 PM KANDERS WARREN B CEO AND CHAIRMAN Mar 19 '24 Sale 35.00 1,438,127 50,334,445 12,184,918 Mar 20 04:17 PM Browers Blaine PRESIDENT Dec 12 '23 Sale 32.05 7,564 242,431 70,069 Dec 13 04:15 PM Browers Blaine PRESIDENT Dec 11 '23 Sale 32.57 7,436 242,222 77,633 Dec 13 04:15 PM KANDERS WARREN B CEO AND CHAIRMAN Dec 07 '23 Sale 32.35 9,608 310,819 13,883,513 Dec 11 04:15 PM KANDERS WARREN B CEO AND CHAIRMAN Dec 08 '23 Sale 32.28 9,608 310,146 13,873,905 Dec 11 04:15 PM KANDERS WARREN B CEO AND CHAIRMAN Dec 05 '23 Sale 33.25 9,608 319,466 13,902,729 Dec 07 04:15 PM KANDERS WARREN B CEO AND CHAIRMAN Dec 06 '23 Sale 32.80 9,608 315,142 13,893,121 Dec 07 04:15 PM KANDERS WARREN B CEO AND CHAIRMAN Dec 04 '23 Sale 32.77 9,608 314,854 13,912,337 Dec 05 04:15 PM KANDERS WARREN B CEO AND CHAIRMAN Dec 01 '23 Sale 32.42 9,608 311,491 13,921,945 Dec 05 04:15 PM KANDERS WARREN B CEO AND CHAIRMAN Nov 30 '23 Sale 32.75 9,608 314,662 13,931,553 Dec 01 04:15 PM KANDERS WARREN B CEO AND CHAIRMAN Nov 29 '23 Sale 32.36 9,608 310,915 13,941,161 Dec 01 04:15 PM KANDERS WARREN B CEO AND CHAIRMAN Nov 28 '23 Sale 32.32 9,608 310,531 13,950,769 Nov 29 04:15 PM KANDERS WARREN B CEO AND CHAIRMAN Nov 27 '23 Sale 32.23 9,608 309,666 13,960,377 Nov 29 04:15 PM KANDERS WARREN B CEO AND CHAIRMAN Nov 24 '23 Sale 31.94 7,548 241,083 13,969,985 Nov 27 04:15 PM KANDERS WARREN B CEO AND CHAIRMAN Nov 22 '23 Sale 32.01 7,372 235,978 13,977,533 Nov 27 04:15 PM KANDERS WARREN B CEO AND CHAIRMAN Nov 21 '23 Sale 31.45 11,000 345,950 13,984,905 Nov 22 04:15 PM KANDERS WARREN B CEO AND CHAIRMAN Nov 20 '23 Sale 32.08 3,000 96,240 13,995,905 Nov 22 04:15 PM SOKOLOW NICOLAS Director Nov 15 '23 Sale 31.94 26,000 830,443 51,347 Nov 17 04:15 PM SOKOLOW NICOLAS Director Nov 15 '23 Sale 31.92 2,000 63,833 587,620 Nov 17 04:15 PM
Index S&P 500
P/E 59.57
EPS (ttm) 4.03
Insider Own 0.32%
Shs Outstand 98.88M
Perf Week 0.89%
Market Cap 23.65B
Forward P/E 23.74
EPS next Y 10.10
Insider Trans -15.04%
Shs Float 98.30M
Perf Month 2.69%
Income 400.09M
PEG 5.96
EPS next Q 2.13
Inst Own 100.40%
Short Float 2.63%
Perf Quarter 4.05%
Sales 5.44B
P/S 4.35
EPS this Y 11.71%
Inst Trans 0.33%
Short Ratio 5.81
Perf Half Y 2.92%
Book/sh 64.32
P/B 3.73
EPS next Y 10.28%
ROA 5.25%
Short Interest 2.59M
Perf Year 7.16%
Cash/sh 2.01
P/C 119.25
EPS next 5Y 10.00%
ROE 8.76%
52W Range 195.47 - 245.81
Perf YTD 9.08%
Dividend Est. 2.30 (0.96%)
P/FCF 39.81
EPS past 5Y 1.36%
ROI 4.58%
52W High -2.44%
Beta 0.84
Dividend TTM 2.13 (0.89%)
Quick Ratio 1.49
Sales past 5Y 14.25%
Gross Margin 43.25%
52W Low 22.69%
ATR (14) 4.69
Dividend Ex-Date Sep 05, 2024
Current Ratio 2.33
EPS Y/Y TTM 229.21%
Oper. Margin 16.75%
RSI (14) 58.47
Volatility 2.20% 1.75%
Employees 18179
Debt/Eq 0.39
Sales Y/Y TTM 6.90%
Profit Margin 7.36%
Recom 2.00
Target Price 250.00
Option/Short Yes / Yes
LT Debt/Eq 0.37
EPS Q/Q 17.52%
Payout 53.33%
Rel Volume 0.82
Prev Close 239.05
Sales Surprise 0.55%
EPS Surprise 8.24%
Sales Q/Q -0.39%
Earnings Aug 06 AMC
Avg Volume 445.63K
Price 239.82
SMA20 1.61%
SMA50 4.08%
SMA200 8.20%
Trades
Volume 364,088
Change 0.32%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-06-24 Resumed
KeyBanc Capital Markets
Overweight
$253
May-30-23 Initiated
Morgan Stanley
Equal-Weight
$206
Apr-14-23 Downgrade
Piper Sandler
Overweight → Neutral
$215 → $197
Sep-23-22 Downgrade
Needham
Buy → Hold
Jul-14-22 Initiated
Piper Sandler
Overweight
$240
Apr-07-22 Initiated
Wolfe Research
Outperform
$275
May-26-21 Upgrade
Needham
Hold → Buy
$233
Feb-04-21 Upgrade
KeyBanc Capital Markets
Sector Weight → Overweight
Sep-02-20 Initiated
Robert W. Baird
Outperform
$175
Jun-09-20 Initiated
Needham
Hold
Jul-10-19 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
Jan-03-18 Downgrade
Raymond James
Outperform → Mkt Perform
Jun-05-17 Downgrade
Wellington Shields
Gradually Accumulate → Hold
May-03-17 Upgrade
KeyBanc Capital Mkts
Sector Weight → Overweight
Nov-30-16 Initiated
Goldman
Neutral
$71
Jun-03-16 Upgrade
Northcoast
Neutral → Buy
Jun-12-15 Downgrade
Raymond James
Strong Buy → Outperform
May-07-13 Downgrade
Griffin Securities
Buy → Hold
Feb-08-13 Reiterated
Griffin Securities
Buy
$40 → $45
Aug-03-12 Upgrade
JMP Securities
Mkt Perform → Mkt Outperform
Show Previous Ratings
Sep-05-24 11:31AM
Aug-26-24 04:30PM
Aug-12-24 09:15AM
Aug-09-24 01:06AM
Aug-08-24 02:20AM
(Thomson Reuters StreetEvents)
05:10PM
Loading…
Aug-07-24 05:10PM
10:26AM
Aug-06-24 07:00PM
05:50PM
04:47PM
(Associated Press Finance)
04:30PM
Aug-05-24 09:04AM
Aug-01-24 09:15AM
Jul-31-24 04:30PM
Jul-23-24 04:30PM
09:00AM
Loading…
09:00AM
Jul-11-24 09:10AM
Jul-08-24 07:29AM
Jun-17-24 07:02AM
Jun-07-24 11:30AM
Jun-03-24 07:00AM
Jun-01-24 01:03AM
May-31-24 05:47AM
May-20-24 04:36PM
May-17-24 04:37PM
May-16-24 04:37PM
May-15-24 07:02PM
May-13-24 11:02AM
May-10-24 12:15PM
11:05AM
08:05AM
Loading…
08:05AM
07:16AM
06:07AM
May-09-24 10:25PM
(Thomson Reuters StreetEvents) +7.57%
04:42PM
12:40PM
12:27PM
May-08-24 06:00PM
05:45PM
05:21PM
04:51PM
(Associated Press Finance)
04:30PM
May-03-24 09:15AM
May-02-24 08:58AM
May-01-24 04:30PM
Apr-28-24 06:32PM
Apr-24-24 04:30PM
Apr-22-24 02:15PM
Apr-11-24 07:30AM
06:58AM
06:50AM
Apr-09-24 09:35AM
Mar-28-24 11:17AM
Mar-08-24 11:30AM
Feb-27-24 12:21PM
Feb-15-24 09:50AM
Feb-12-24 09:45AM
Feb-09-24 08:34AM
12:33AM
Feb-08-24 10:39PM
(Thomson Reuters StreetEvents)
08:57AM
07:32AM
Feb-07-24 06:33PM
06:30PM
05:45PM
04:53PM
04:44PM
(Associated Press Finance)
04:30PM
Feb-02-24 09:15AM
Jan-31-24 10:00AM
Jan-30-24 04:30PM
06:57AM
Jan-23-24 04:30PM
Jan-04-24 07:52AM
Dec-07-23 11:30AM
Nov-21-23 06:52AM
Nov-09-23 02:54PM
Nov-08-23 10:45PM
(Thomson Reuters StreetEvents) -5.46%
05:27PM
12:10PM
06:49AM
12:10AM
Nov-07-23 06:30PM
05:39PM
04:58PM
(Associated Press Finance)
04:30PM
Nov-02-23 11:39AM
Nov-01-23 10:01AM
Oct-31-23 06:05PM
11:28AM
10:01AM
Oct-30-23 09:48AM
Oct-27-23 10:12AM
Oct-24-23 04:30PM
Oct-20-23 09:45AM
Oct-17-23 11:17AM
Oct-03-23 09:45AM
Sep-27-23 07:35PM
07:51AM
Sep-22-23 01:03PM
STERIS Plc engages in the provision of healthcare and life science products and service solutions. It operates through the following segments: Healthcare, Life Sciences, Applied Sterilization Technologies, and Dental. The Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. The Life Sciences segment designs, manufactures, and sells consumable products, equipment maintenance, specialty services, and capital equipment. The Applied Sterilization Technologies segment is involved in contract sterilization and testing services for medical device and pharmaceutical manufacturers. The Dental segment offers a comprehensive offering for dental practitioners and dental schools, offering instruments, infection prevention consumables and instrument management systems. The company was founded in 1985 and is headquartered in Dublin, Ireland.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
HOLLAND CHRISTOPHER S Director Aug 08 '24 Sale 239.68 473 113,369 582 Aug 12 04:34 PM Majors Cary L SVP and President, Healthcare Jun 05 '24 Option Exercise 114.22 4,932 563,333 17,986 Jun 07 04:32 PM Majors Cary L SVP and President, Healthcare Jun 05 '24 Sale 229.63 4,932 1,132,535 13,054 Jun 07 04:32 PM Madsen Julia Senior VP, Life Sciences Jun 05 '24 Option Exercise 76.26 3,652 278,520 12,923 Jun 07 04:31 PM Madsen Julia Senior VP, Life Sciences Jun 05 '24 Sale 230.00 3,652 839,960 9,671 Jun 07 04:31 PM Breeden Richard C Director May 21 '24 Option Exercise 51.53 4,584 236,214 32,554 May 23 04:34 PM Tamaro Renato V.P. & Corporate Treasurer May 16 '24 Option Exercise 114.22 1,154 131,810 7,831 May 20 04:31 PM Tamaro Renato V.P. & Corporate Treasurer May 16 '24 Sale 231.64 1,154 267,313 6,677 May 20 04:31 PM FELDMANN CYNTHIA L Director May 15 '24 Option Exercise 86.23 2,000 172,460 2,705 May 17 04:33 PM FELDMANN CYNTHIA L Director May 15 '24 Sale 237.65 2,000 475,300 705 May 17 04:33 PM TOKICH MICHAEL J Sr. Vice Pres., CFO May 15 '24 Option Exercise 77.07 32,000 2,466,240 74,464 May 17 04:31 PM TOKICH MICHAEL J Sr. Vice Pres., CFO May 15 '24 Sale 235.39 32,000 7,532,366 42,464 May 17 04:31 PM Sohi Mohsen Director May 14 '24 Option Exercise 51.53 2,037 104,967 24,398 May 16 04:33 PM Sohi Mohsen Director May 14 '24 Sale 233.72 2,037 476,093 22,361 May 16 04:33 PM Burton Karen L VP & CAO May 14 '24 Sale 235.95 3,000 707,850 3,759 May 16 04:31 PM KOSECOFF JACQUELINE B Director May 13 '24 Option Exercise 51.53 4,584 236,214 4,584 May 15 04:39 PM KOSECOFF JACQUELINE B Director May 13 '24 Sale 231.53 4,584 1,061,334 0 May 15 04:39 PM Majors Cary L SVP and President, Healthcare May 13 '24 Sale 232.13 2,024 469,831 11,369 May 15 04:38 PM Xilas Andrew SVP and GM, Dental Dec 04 '23 Option Exercise 0.00 333 0 6,569 Dec 06 04:35 PM Xilas Andrew SVP and GM, Dental Oct 09 '23 Option Exercise 0.00 605 0 6,414 Oct 11 04:35 PM
Index S&P 500
P/E 21.85
EPS (ttm) 4.80
Insider Own 0.14%
Shs Outstand 205.60M
Perf Week -8.60%
Market Cap 21.34B
Forward P/E 12.13
EPS next Y 8.64
Insider Trans -4.86%
Shs Float 203.37M
Perf Month -0.95%
Income 997.10M
PEG 3.12
EPS next Q 1.79
Inst Own 94.11%
Short Float 2.85%
Perf Quarter -7.55%
Sales 7.52B
P/S 2.84
EPS this Y 6.41%
Inst Trans -0.06%
Short Ratio 3.73
Perf Half Y -17.71%
Book/sh 62.18
P/B 1.69
EPS next Y 7.54%
ROA 4.66%
Short Interest 5.79M
Perf Year -14.56%
Cash/sh 2.06
P/C 50.81
EPS next 5Y 7.00%
ROE 7.94%
52W Range 102.00 - 133.90
Perf YTD -13.88%
Dividend Est. 0.86 (0.82%)
P/FCF 21.83
EPS past 5Y -
ROI 5.97%
52W High -21.73%
Beta 1.04
Dividend TTM 0.96 (0.92%)
Quick Ratio 0.63
Sales past 5Y -1.20%
Gross Margin 61.82%
52W Low 2.75%
ATR (14) 2.47
Dividend Ex-Date Sep 30, 2024
Current Ratio 1.29
EPS Y/Y TTM 99.18%
Oper. Margin 18.01%
RSI (14) 33.97
Volatility 2.24% 1.69%
Employees 18000
Debt/Eq 0.46
Sales Y/Y TTM 4.58%
Profit Margin 13.25%
Recom 2.59
Target Price 124.80
Option/Short Yes / Yes
LT Debt/Eq 0.31
EPS Q/Q 17.80%
Payout 19.66%
Rel Volume 1.57
Prev Close 104.47
Sales Surprise 0.10%
EPS Surprise 0.95%
Sales Q/Q 3.87%
Earnings Aug 07 BMO
Avg Volume 1.55M
Price 104.81
SMA20 -6.21%
SMA50 -4.72%
SMA200 -11.25%
Trades
Volume 2,446,474
Change 0.33%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-01-24 Downgrade
Piper Sandler
Overweight → Neutral
$140 → $115
May-30-24 Initiated
Goldman
Neutral
$129
May-21-24 Upgrade
Argus
Hold → Buy
$150
Jan-04-24 Downgrade
Evercore ISI
Outperform → In-line
$135 → $125
Oct-20-23 Initiated
ROTH MKM
Neutral
$120
Aug-28-23 Upgrade
BTIG Research
Neutral → Buy
$139
May-03-23 Upgrade
BofA Securities
Underperform → Neutral
Apr-11-23 Upgrade
Evercore ISI
In-line → Outperform
$135 → $148
Mar-31-23 Upgrade
Jefferies
Underperform → Hold
$115 → $130
Mar-29-23 Initiated
UBS
Sell
$112
Mar-10-23 Upgrade
Piper Sandler
Neutral → Overweight
$135 → $145
Jan-09-23 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$125 → $141
Jan-05-23 Upgrade
Raymond James
Mkt Perform → Outperform
$144
Jan-03-23 Downgrade
Evercore ISI
Outperform → In-line
$130
Nov-23-22 Upgrade
Wells Fargo
Underweight → Equal Weight
Oct-18-22 Initiated
Barclays
Underweight
$104
Oct-12-22 Initiated
Jefferies
Underperform
$95
May-27-22 Downgrade
Needham
Buy → Hold
Apr-13-22 Downgrade
Truist
Buy → Hold
$128 → $142
Apr-01-22 Downgrade
Citigroup
Buy → Neutral
$125.15 → $135
Show Previous Ratings
Sep-06-24 11:31AM
Sep-05-24 05:16PM
04:04PM
(Investor's Business Daily)
03:59PM
03:29PM
11:37AM
Loading…
11:37AM
07:30AM
Aug-29-24 04:43PM
Aug-21-24 07:30AM
Aug-15-24 09:02AM
Aug-12-24 08:53AM
Aug-09-24 06:54AM
01:12AM
Aug-08-24 09:40AM
06:32AM
05:01PM
Loading…
Aug-07-24 05:01PM
12:13PM
09:30AM
07:44AM
07:40AM
06:39AM
(Associated Press Finance)
06:30AM
06:30AM
Aug-06-24 04:09PM
Aug-02-24 09:15AM
Jul-29-24 07:00AM
Jul-25-24 10:48AM
Jul-24-24 06:12AM
Jul-19-24 09:40AM
Jul-17-24 09:50AM
07:30AM
Loading…
Jul-08-24 07:30AM
Jun-20-24 07:30AM
Jun-14-24 09:16AM
07:29AM
Jun-13-24 11:22AM
06:53AM
Jun-12-24 08:38AM
06:00AM
Jun-11-24 07:30AM
Jun-04-24 12:14PM
07:30AM
01:38AM
May-30-24 12:21PM
May-29-24 05:02PM
09:40AM
May-23-24 07:10PM
May-21-24 07:55AM
May-20-24 08:30AM
06:00AM
May-15-24 08:59AM
03:11AM
May-13-24 09:40AM
07:00AM
May-09-24 07:58AM
May-06-24 07:30AM
May-03-24 12:57PM
11:17AM
11:07AM
09:53AM
09:41AM
08:31AM
08:23AM
08:18AM
07:37AM
07:19AM
07:08AM
07:04AM
03:10AM
May-02-24 01:52PM
11:56AM
11:54AM
11:19AM
10:54AM
09:30AM
07:52AM
07:48AM
07:40AM
07:19AM
06:38AM
(Associated Press Finance)
06:30AM
Apr-29-24 09:16AM
Apr-26-24 12:10PM
09:40AM
Apr-25-24 10:01AM
Apr-19-24 10:27AM
Apr-10-24 09:40AM
Apr-04-24 07:30AM
Apr-03-24 07:30AM
Mar-27-24 12:23PM
Mar-13-24 04:30PM
Mar-11-24 08:25AM
Mar-08-24 11:29PM
Feb-29-24 09:40AM
Feb-22-24 07:30AM
05:25AM
Feb-21-24 07:35PM
07:17AM
07:00AM
Feb-18-24 01:26PM
Feb-15-24 06:09AM
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
VAN ZUILEN WILFRED Group Pres, EMEA Jul 01 '24 Option Exercise 0.00 2,633 0 9,800 Jul 03 04:23 PM Yi Sang Group President, Asia Pacific May 31 '24 Sale 114.69 12,857 1,474,582 5,322 Jun 04 04:21 PM Stellato Paul A VP, Controller & CAO Jun 01 '24 Option Exercise 0.00 627 0 1,579 Jun 04 04:20 PM Winkler Lori SVP and CHRO Apr 01 '24 Option Exercise 0.00 772 0 3,551 Apr 03 04:35 PM Winkler Lori SVP and CHRO Mar 06 '24 Option Exercise 0.00 1,757 0 3,207 Mar 08 05:05 PM VAN ZUILEN WILFRED Group Pres, EMEA Mar 06 '24 Option Exercise 0.00 2,163 0 7,427 Mar 08 05:05 PM Upadhyay Suketu Exec. VP, CFO Mar 06 '24 Option Exercise 0.00 4,561 0 22,683 Mar 08 05:05 PM Tornos Ivan President & CEO Mar 06 '24 Option Exercise 0.00 10,270 0 32,395 Mar 08 05:04 PM Stellato Paul A VP, Controller & CAO Mar 06 '24 Option Exercise 0.00 609 0 1,176 Mar 08 05:04 PM Phipps Chad F Sr. VP/Gen Counsel/Secretary Mar 06 '24 Option Exercise 0.00 2,095 0 50,046 Mar 08 05:03 PM Ellingson Rachel SVP & Chief Strategy Officer Mar 06 '24 Option Exercise 0.00 1,419 0 7,291 Mar 08 05:03 PM Bezjak Mark President, Americas Mar 06 '24 Option Exercise 0.00 1,622 0 4,753 Mar 08 05:03 PM Yi Sang Group President, Asia Pacific Mar 07 '24 Option Exercise 91.53 1,705 156,059 19,884 Mar 08 05:03 PM Yi Sang Group President, Asia Pacific Mar 06 '24 Option Exercise 0.00 2,365 0 18,179 Mar 08 05:03 PM Yi Sang Group President, Asia Pacific Mar 07 '24 Sale 126.86 1,705 216,296 18,179 Mar 08 05:03 PM Phipps Chad F Sr. VP/Gen Counsel/Secretary Mar 01 '24 Option Exercise 0.00 1,641 0 48,597 Mar 05 05:02 PM Yi Sang Group President, Asia Pacific Mar 01 '24 Option Exercise 0.00 2,052 0 15,814 Mar 05 04:59 PM Winkler Lori SVP and CHRO Mar 02 '24 Option Exercise 0.00 186 0 1,496 Mar 05 04:58 PM Upadhyay Suketu Exec. VP, CFO Feb 25 '24 Option Exercise 0.00 7,043 0 20,213 Feb 27 08:58 PM Tornos Ivan President & CEO Feb 25 '24 Option Exercise 0.00 7,513 0 25,153 Feb 27 08:58 PM Phipps Chad F Sr. VP/Gen Counsel/Secretary Feb 25 '24 Option Exercise 0.00 4,580 0 48,725 Feb 27 08:57 PM Ellingson Rachel SVP & Chief Strategy Officer Feb 25 '24 Option Exercise 0.00 1,762 0 6,460 Feb 27 08:57 PM Winkler Lori SVP and CHRO Feb 25 '24 Option Exercise 0.00 1,294 0 1,661 Feb 27 08:56 PM Bezjak Mark President, Americas Feb 25 '24 Option Exercise 0.00 1,528 0 3,535 Feb 27 08:56 PM Yi Sang Group President, Asia Pacific Feb 25 '24 Option Exercise 0.00 5,047 0 13,762 Feb 27 08:55 PM Phipps Chad F Sr. VP/Gen Counsel/Secretary Feb 22 '24 Option Exercise 91.53 26,156 2,394,059 70,301 Feb 26 06:02 PM Phipps Chad F Sr. VP/Gen Counsel/Secretary Feb 22 '24 Sale 128.62 26,156 3,364,126 44,145 Feb 26 06:02 PM Jafry Syed A. Director Nov 09 '23 Buy 104.75 2,135 223,641 4,060 Nov 13 04:02 PM
Index -
P/E -
EPS (ttm) -0.26
Insider Own 10.98%
Shs Outstand 27.14M
Perf Week -12.38%
Market Cap 113.36M
Forward P/E -
EPS next Y -0.04
Insider Trans 1.92%
Shs Float 26.91M
Perf Month 3.02%
Income -9.45M
PEG -
EPS next Q -0.04
Inst Own 47.67%
Short Float 3.12%
Perf Quarter 6.84%
Sales 21.11M
P/S 5.37
EPS this Y 32.74%
Inst Trans -0.47%
Short Ratio 1.82
Perf Half Y 6.53%
Book/sh 0.32
P/B 11.70
EPS next Y 81.42%
ROA -64.07%
Short Interest 0.84M
Perf Year 307.61%
Cash/sh 0.30
P/C 12.62
EPS next 5Y -0.47%
ROE -102.14%
52W Range 0.84 - 5.64
Perf YTD -25.15%
Dividend Est. -
P/FCF -
EPS past 5Y 59.45%
ROI -97.13%
52W High -33.51%
Beta 1.58
Dividend TTM -
Quick Ratio 1.94
Sales past 5Y 54.66%
Gross Margin 67.35%
52W Low 348.14%
ATR (14) 0.30
Dividend Ex-Date -
Current Ratio 2.34
EPS Y/Y TTM 68.87%
Oper. Margin -44.82%
RSI (14) 43.64
Volatility 6.89% 6.75%
Employees 106
Debt/Eq 0.04
Sales Y/Y TTM 21.22%
Profit Margin -44.75%
Recom 1.00
Target Price 7.04
Option/Short Yes / Yes
LT Debt/Eq 0.01
EPS Q/Q 17.13%
Payout -
Rel Volume 0.18
Prev Close 3.77
Sales Surprise 12.21%
EPS Surprise 57.14%
Sales Q/Q 26.22%
Earnings Aug 06 AMC
Avg Volume 460.86K
Price 3.75
SMA20 -4.13%
SMA50 -9.77%
SMA200 -0.22%
Trades
Volume 81,267
Change -0.53%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-31-24 Initiated
Craig Hallum
Buy
$7
May-20-24 Initiated
Lake Street
Buy
$7
Dec-15-23 Initiated
H.C. Wainwright
Buy
$6.50
Nov-11-20 Upgrade
ROTH Capital
Neutral → Buy
$5 → $7
May-27-20 Initiated
Dougherty & Company
Buy
$8.50
Oct-02-17 Initiated
H.C. Wainwright
Buy
$12
Sep-05-24 04:15PM
Aug-06-24 04:05PM
Jul-30-24 04:05PM
(Business Wire) -5.53%
+7.21%
Jul-27-24 07:40AM
Jul-26-24 06:05PM
08:30AM
Loading…
Jul-08-24 08:30AM
Jun-11-24 10:50AM
Jun-05-24 05:58PM
Jun-01-24 02:42AM
May-17-24 07:01PM
May-10-24 04:03PM
01:01PM
May-09-24 01:16PM
May-08-24 04:05PM
May-06-24 01:19PM
08:30AM
Loading…
08:30AM
May-01-24 05:21PM
(Business Wire) +7.95%
+11.05%
Mar-28-24 04:05PM
(Business Wire) -6.57%
-5.50%
Mar-18-24 11:00AM
Mar-08-24 10:15AM
Mar-07-24 06:00PM
04:05PM
Mar-01-24 08:00AM
Feb-29-24 04:05PM
Jan-19-24 04:05PM
Jan-17-24 08:05AM
08:00AM
Dec-20-23 08:50AM
Dec-12-23 07:00AM
Dec-01-23 10:00AM
04:16PM
Loading…
Nov-20-23 04:16PM
Nov-08-23 11:47AM
Nov-07-23 04:05PM
Nov-06-23 08:30AM
Nov-02-23 10:08AM
Oct-31-23 04:05PM
Aug-29-23 04:05PM
Aug-28-23 12:38PM
Aug-25-23 07:00AM
Aug-24-23 07:33PM
04:15PM
04:05PM
Aug-21-23 04:05PM
(Business Wire) +10.80%
-6.91%
Aug-09-23 05:30PM
04:05PM
Aug-02-23 04:05PM
Jul-05-23 10:50AM
Jul-03-23 08:30AM
Jun-14-23 04:05PM
May-22-23 09:55AM
May-10-23 06:05PM
May-09-23 07:05PM
May-05-23 07:45AM
May-03-23 04:05PM
Apr-10-23 08:30AM
Mar-16-23 05:30AM
(The Wall Street Journal)
Mar-15-23 08:30AM
Mar-14-23 11:11AM
Mar-13-23 09:45AM
08:30AM
Mar-07-23 10:12AM
Mar-06-23 04:05PM
Feb-06-23 04:05PM
Feb-01-23 04:25PM
Jan-30-23 04:05PM
Jan-17-23 04:05PM
Jan-12-23 08:30AM
Jan-10-23 04:17PM
Dec-07-22 05:00PM
Dec-05-22 08:30AM
Nov-21-22 03:04PM
Nov-10-22 05:55PM
04:05PM
Nov-09-22 05:25PM
Nov-03-22 04:05PM
Oct-05-22 04:30PM
Sep-07-22 08:30AM
Aug-30-22 08:30AM
Aug-03-22 06:35PM
04:05PM
Jul-28-22 10:03AM
Jul-27-22 04:15PM
10:04AM
Jul-18-22 12:00PM
Jul-07-22 04:05PM
Jun-14-22 02:45PM
Jun-09-22 04:05PM
May-25-22 10:34AM
May-11-22 06:05PM
04:05PM
May-04-22 04:15PM
Apr-04-22 04:15PM
Mar-09-22 05:35PM
04:15PM
04:05PM
Mar-02-22 04:15PM
Feb-17-22 04:15PM
Feb-14-22 08:30AM
Jan-18-22 07:30AM
Jan-13-22 04:30PM
Myomo, Inc. is a wearable medical robotics company, which engages in the business of developing, designing, and producing myoelectric orthotics for people with neuromuscular disorders. The firm is also involved in selling products through various other sales channels including through orthotics and prosthetics providers, veterans' administration, and to distributors in certain accounts and geographic markets. The company was founded by Stephen Kelly, John McBean, Mira Sahney, and Kailas N. Narendran on September 1, 2004 and is headquartered in Boston, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Kovelman Harry Chief Medical Officer Sep 03 '24 Sale 4.01 2,029 8,140 130,395 Sep 05 08:27 AM Harry Kovelman Officer Sep 04 '24 Proposed Sale 3.89 139 541 Sep 04 06:26 PM Harry Kovelman Officer Sep 03 '24 Proposed Sale 4.00 18,500 74,000 Sep 03 05:55 PM Harry Kovelman Officer Aug 05 '24 Proposed Sale 3.96 128 507 Aug 05 11:53 AM KIRK THOMAS F Director May 29 '24 Buy 3.50 50,000 175,000 236,499 May 31 05:43 PM Kovelman Harry Chief Medical Officer May 15 '24 Sale 3.69 35,426 130,839 98,009 May 17 04:57 PM KIRK THOMAS F Director Mar 14 '24 Buy 3.50 50,000 175,000 186,499 Mar 18 07:48 AM KIRK THOMAS F Director Nov 20 '23 Buy 3.10 50,000 155,000 136,499 Dec 14 07:46 PM Morris Milton Mayo Director Sep 08 '23 Buy 1.06 15,000 15,867 77,933 Sep 11 05:05 PM
Index RUT
P/E -
EPS (ttm) -3.97
Insider Own 1.61%
Shs Outstand 23.72M
Perf Week -11.37%
Market Cap 268.04M
Forward P/E -
EPS next Y -1.68
Insider Trans -2.55%
Shs Float 23.34M
Perf Month 1.99%
Income -92.44M
PEG -
EPS next Q -0.50
Inst Own 91.36%
Short Float 5.78%
Perf Quarter 33.57%
Sales 326.65M
P/S 0.82
EPS this Y 56.47%
Inst Trans -0.04%
Short Ratio 6.91
Perf Half Y 49.87%
Book/sh 7.91
P/B 1.43
EPS next Y 12.44%
ROA -27.06%
Short Interest 1.35M
Perf Year 88.02%
Cash/sh 5.11
P/C 2.21
EPS next 5Y -
ROE -39.99%
52W Range 4.13 - 13.33
Perf YTD 105.83%
Dividend Est. -
P/FCF -
EPS past 5Y -
ROI -44.94%
52W High -15.23%
Beta 1.05
Dividend TTM -
Quick Ratio 2.37
Sales past 5Y -1.72%
Gross Margin 45.69%
52W Low 173.61%
ATR (14) 0.62
Dividend Ex-Date -
Current Ratio 2.70
EPS Y/Y TTM 5.41%
Oper. Margin -16.91%
RSI (14) 47.12
Volatility 4.82% 5.04%
Employees 834
Debt/Eq 0.11
Sales Y/Y TTM -6.48%
Profit Margin -28.30%
Recom 3.00
Target Price 9.50
Option/Short Yes / Yes
LT Debt/Eq 0.10
EPS Q/Q 44.24%
Payout -
Rel Volume 0.67
Prev Close 11.70
Sales Surprise 7.59%
EPS Surprise 48.30%
Sales Q/Q 6.13%
Earnings Aug 06 AMC
Avg Volume 195.37K
Price 11.30
SMA20 -8.51%
SMA50 9.92%
SMA200 43.30%
Trades
Volume 130,904
Change -3.42%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-15-24 Upgrade
William Blair
Mkt Perform → Outperform
Aug-08-23 Downgrade
JP Morgan
Overweight → Neutral
$15 → $8
Jul-14-23 Downgrade
Needham
Buy → Hold
Jan-17-23 Downgrade
William Blair
Outperform → Mkt Perform
Dec-09-21 Upgrade
Needham
Hold → Buy
$47
Nov-02-21 Upgrade
JP Morgan
Underweight → Neutral
$45
Aug-05-21 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
Jun-04-21 Upgrade
William Blair
Mkt Perform → Outperform
Dec-14-20 Upgrade
KeyBanc Capital Markets
Sector Weight → Overweight
$60
Jul-23-20 Downgrade
Needham
Buy → Hold
May-06-20 Reiterated
Needham
Buy
$80 → $75
Nov-06-19 Upgrade
Needham
Hold → Buy
$90
Sep-13-19 Reiterated
Piper Jaffray
Overweight
$80 → $80
Aug-08-19 Downgrade
SVB Leerink
Outperform → Mkt Perform
$78 → $47
Aug-08-19 Downgrade
Stifel
Buy → Hold
Aug-07-19 Downgrade
Needham
Buy → Hold
Jun-28-19 Downgrade
Needham
Strong Buy → Buy
$111 → $91
May-08-19 Reiterated
Needham
Strong Buy
$191 → $111
May-08-19 Downgrade
JP Morgan
Overweight → Neutral
$175 → $72
Feb-27-19 Reiterated
Needham
Strong Buy
$280 → $191
Show Previous Ratings
Sep-05-24 08:30AM
Aug-22-24 01:16PM
Aug-08-24 12:00PM
Aug-07-24 11:34AM
Aug-06-24 06:05PM
05:06PM
Loading…
05:06PM
(Associated Press Finance)
04:05PM
Jul-22-24 06:24AM
Jul-16-24 08:30AM
Jul-15-24 09:00AM
Jul-03-24 04:10PM
Jun-06-24 11:31AM
Jun-03-24 04:05PM
May-09-24 01:29PM
May-08-24 01:27PM
07:14AM
Loading…
07:14AM
(Thomson Reuters StreetEvents)
04:07AM
May-07-24 09:55PM
08:00PM
06:33PM
05:32PM
(Associated Press Finance)
04:05PM
Apr-10-24 08:30AM
Mar-28-24 11:30AM
11:26AM
Mar-25-24 08:30AM
Mar-07-24 04:00PM
Feb-29-24 08:28AM
Feb-28-24 09:22AM
06:47AM
(Thomson Reuters StreetEvents)
07:30PM
Loading…
Feb-27-24 07:30PM
06:25PM
05:30PM
(Associated Press Finance)
04:48PM
04:05PM
Feb-26-24 09:15AM
Feb-23-24 09:00AM
Feb-01-24 07:03AM
Jan-30-24 04:00PM
(Business Wire) +5.58%
+12.31%
Jan-24-24 04:00PM
Jan-08-24 07:10AM
Jan-02-24 09:29AM
Dec-07-23 11:31AM
Nov-13-23 08:30AM
Nov-10-23 09:30AM
Nov-09-23 02:30PM
Nov-08-23 11:09AM
09:57AM
Nov-07-23 04:36PM
(Associated Press Finance)
04:05PM
Oct-16-23 09:55AM
Oct-13-23 09:35AM
Oct-10-23 04:00PM
Oct-09-23 11:15AM
Sep-18-23 08:30AM
Sep-07-23 08:30AM
Aug-08-23 11:40AM
08:30AM
06:07AM
(Thomson Reuters StreetEvents)
Aug-07-23 08:30PM
05:25PM
04:14PM
04:01PM
08:30AM
Jul-17-23 12:46PM
Jul-14-23 11:01AM
Jul-13-23 08:30AM
Jul-12-23 06:58AM
Jun-02-23 06:46PM
May-18-23 04:53PM
May-16-23 06:26AM
May-15-23 05:37PM
May-05-23 11:29AM
May-04-23 07:00PM
06:15PM
05:06PM
04:05PM
Apr-26-23 08:00PM
Apr-21-23 02:37PM
Apr-18-23 07:31AM
Apr-06-23 04:05PM
Apr-04-23 06:09PM
Mar-27-23 01:22PM
10:22AM
Mar-22-23 04:05PM
08:24AM
Mar-08-23 08:30AM
Mar-07-23 05:50AM
Feb-24-23 11:03AM
Feb-23-23 04:10PM
04:02PM
Feb-22-23 06:13AM
Feb-20-23 10:00AM
Feb-16-23 10:01AM
Feb-03-23 08:02AM
Jan-13-23 08:23AM
Jan-10-23 08:30AM
08:00AM
Dec-27-22 10:49AM
Dec-13-22 04:00PM
Inogen, Inc. is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its products include Inogen One G4 system, Inogen One G3 system, Inogen One G5 system, Inogen TAV, and Inogen at Home. The company was founded by Alison Perry, Alison K. Bauerlein, Brenton Taylor, and Byron Myers on November 27, 2001 and is headquartered in Goleta, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
JASON SOMER Officer Aug 09 '24 Proposed Sale 12.03 4,690 56,423 Aug 09 04:53 PM Somer Jason EVP, Gen. Counsel & Secretary Jun 01 '24 Option Exercise 0.00 577 0 5,029 Jun 04 05:08 PM Somer Jason EVP, Gen. Counsel & Secretary May 10 '24 Sale 8.56 10,000 85,600 4,452 May 14 06:43 PM Somer Jason EVP, Gen. Counsel & Secretary May 01 '24 Option Exercise 0.00 19,276 0 25,764 May 03 06:15 PM Glezer Stanislav EVP, R&D & Chief Med. Officer May 01 '24 Option Exercise 0.00 32,638 0 48,744 May 03 06:14 PM Somer Jason EVP, Gen. Counsel & Secretary Mar 01 '24 Option Exercise 0.00 7,150 0 11,064 Mar 05 07:10 PM Glezer Stanislav EVP, R&D & Chief Med. Officer Mar 01 '24 Option Exercise 0.00 13,914 0 23,729 Mar 05 07:08 PM Somer Jason EVP, Gen. Counsel & Secretary Dec 01 '23 Option Exercise 0.00 576 0 4,200 Dec 04 06:30 PM Glezer Stanislav EVP, Chief Technology Officer Dec 01 '23 Option Exercise 0.00 4,555 0 12,146 Dec 04 06:29 PM
Index -
P/E 24.38
EPS (ttm) 6.88
Insider Own 6.26%
Shs Outstand 39.32M
Perf Week -6.53%
Market Cap 6.60B
Forward P/E 20.01
EPS next Y 8.38
Insider Trans -1.02%
Shs Float 36.89M
Perf Month -3.05%
Income 271.96M
PEG 1.35
EPS next Q 1.80
Inst Own 84.33%
Short Float 0.84%
Perf Quarter -3.82%
Sales 1.82B
P/S 3.63
EPS this Y 10.10%
Inst Trans 2.12%
Short Ratio 2.09
Perf Half Y -9.76%
Book/sh 26.18
P/B 6.41
EPS next Y 8.33%
ROA 12.24%
Short Interest 0.31M
Perf Year -4.59%
Cash/sh 3.78
P/C 44.35
EPS next 5Y 18.00%
ROE 29.17%
52W Range 147.35 - 200.60
Perf YTD -0.63%
Dividend Est. -
P/FCF 19.54
EPS past 5Y -14.17%
ROI 16.56%
52W High -16.37%
Beta 1.00
Dividend TTM 1.96 (1.17%)
Quick Ratio 1.54
Sales past 5Y 5.87%
Gross Margin 48.51%
52W Low 13.86%
ATR (14) 3.69
Dividend Ex-Date Aug 15, 2024
Current Ratio 2.45
EPS Y/Y TTM 1946.09%
Oper. Margin 22.38%
RSI (14) 30.13
Volatility 2.40% 1.75%
Employees 5100
Debt/Eq 0.61
Sales Y/Y TTM 8.82%
Profit Margin 14.96%
Recom 2.00
Target Price 195.00
Option/Short Yes / Yes
LT Debt/Eq 0.59
EPS Q/Q 7.31%
Payout 126.15%
Rel Volume 0.73
Prev Close 172.41
Sales Surprise 0.41%
EPS Surprise 2.64%
Sales Q/Q 3.39%
Earnings Jul 24 AMC
Avg Volume 148.22K
Price 167.77
SMA20 -5.47%
SMA50 -8.66%
SMA200 -6.69%
Trades
Volume 108,506
Change -2.69%
Date
Action
Analyst
Rating Change
Price Target Change
Jun-12-23 Upgrade
William Blair
Mkt Perform → Outperform
Dec-07-21 Upgrade
Sidoti
Neutral → Buy
$183
Mar-24-20 Upgrade
Sidoti
Neutral → Buy
$113
Jan-10-19 Initiated
William Blair
Mkt Perform
Dec-21-18 Downgrade
Robert W. Baird
Outperform → Neutral
Oct-03-17 Downgrade
Robert W. Baird
Outperform → Neutral
$80
May-22-17 Reiterated
Stifel
Buy
$81 → $91
Apr-27-17 Reiterated
Barrington Research
Outperform
$78 → $88
Feb-27-17 Reiterated
Barrington Research
Outperform
$65 → $78
Oct-31-16 Upgrade
Robert W. Baird
Neutral → Outperform
$57 → $63
Jul-22-16 Downgrade
Robert W. Baird
Outperform → Neutral
$54 → $57
Jun-14-16 Upgrade
Stifel
Hold → Buy
$61
Apr-19-16 Downgrade
Sidoti
Buy → Neutral
Oct-23-15 Reiterated
Barrington Research
Outperform
$60 → $54
Apr-29-15 Upgrade
Global Hunter Securities
Neutral → Accumulate
Feb-19-14 Initiated
Stifel
Hold
Jan-06-14 Upgrade
Robert W. Baird
Neutral → Outperform
Jul-25-13 Reiterated
Dougherty & Company
Buy
$55 → $62
Feb-14-13 Reiterated
Dougherty & Company
Buy
$49 → $55
Jul-18-12 Downgrade
Robert W. Baird
Outperform → Neutral
$47 → $43
Show Previous Ratings
Aug-28-24 04:30PM
08:25AM
Aug-16-24 01:15AM
Aug-01-24 08:00AM
Jul-26-24 01:46AM
(Thomson Reuters StreetEvents)
05:50PM
Loading…
Jul-24-24 05:50PM
04:46PM
(Associated Press Finance)
04:30PM
Jul-23-24 04:45PM
Jul-18-24 04:35PM
12:10PM
Jul-10-24 04:20PM
Jun-17-24 02:30PM
08:45AM
Jun-05-24 04:15PM
08:00AM
Loading…
May-29-24 08:00AM
May-22-24 05:02PM
08:00AM
May-17-24 11:00AM
May-15-24 08:30AM
May-13-24 09:31AM
08:35AM
08:30AM
May-02-24 12:45PM
08:30AM
May-01-24 08:24AM
Apr-30-24 11:21PM
(Thomson Reuters StreetEvents)
Apr-29-24 08:52PM
06:11PM
05:00PM
04:55PM
Loading…
04:55PM
(Associated Press Finance)
04:40PM
Apr-25-24 04:30PM
Apr-23-24 06:15PM
Apr-22-24 04:00PM
Apr-17-24 09:07AM
Apr-03-24 12:00PM
Apr-02-24 05:59PM
Apr-01-24 09:03AM
Mar-13-24 11:30AM
Mar-11-24 12:00PM
Mar-06-24 12:45PM
Feb-28-24 03:04PM
Feb-22-24 04:36PM
04:35PM
Feb-19-24 08:06AM
Feb-16-24 08:21AM
12:28AM
(Thomson Reuters StreetEvents)
Feb-14-24 06:00PM
05:16PM
05:08PM
(Associated Press Finance)
04:45PM
Feb-13-24 05:35PM
Feb-07-24 08:15AM
04:00AM
Jan-24-24 12:00PM
Jan-22-24 09:05AM
Jan-16-24 08:15AM
08:00AM
Dec-20-23 04:45PM
Dec-06-23 08:30AM
Nov-02-23 11:00AM
05:20AM
Nov-01-23 08:30AM
Oct-27-23 08:15AM
Oct-26-23 01:20PM
12:23AM
(Thomson Reuters StreetEvents)
Oct-24-23 06:15PM
06:05PM
04:51PM
(Associated Press Finance)
04:45PM
Oct-19-23 04:45PM
11:41AM
Oct-16-23 05:00PM
Sep-25-23 09:30AM
Sep-13-23 03:00PM
Sep-05-23 08:15AM
Aug-31-23 05:15PM
Aug-30-23 04:15PM
08:52AM
Aug-29-23 02:26PM
Aug-24-23 12:20PM
Aug-05-23 08:06AM
Aug-04-23 03:59AM
Aug-02-23 12:24AM
(Thomson Reuters StreetEvents)
Aug-01-23 04:45PM
Jul-31-23 06:45PM
05:43PM
04:45PM
Jul-26-23 05:00PM
07:05AM
Jul-24-23 07:05AM
Jul-20-23 12:15PM
Jul-13-23 04:45PM
Jul-10-23 08:15AM
Jul-07-23 07:12AM
Jun-29-23 07:06PM
Jun-27-23 08:30AM
Jun-26-23 04:45PM
Jun-21-23 08:00PM
MSA Safety, Inc. engages in the development, manufacture, and sale of safety products, technology, and solutions. It operates through the following geographical segments: Americas, International, and Corporate. The Americas segment includes manufacturing, research, and development facilities in the U.S., Mexico, and Brazil. The International segment consists of companies in Europe, the Middle East, Africa, and the Asia Pacific region. The Corporate segment focuses on the general and administrative expenses incurred in its corporate headquarters. The company was founded in 1914 and is headquartered in Butler, PA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Vartanian Nishan J. CEO Jul 31 '24 Sale 189.00 3,945 745,605 31,953 Aug 01 11:55 AM NISHAN J VARTANIAN & PAMELA A Non-Executive Director Jul 31 '24 Proposed Sale 189.00 3,945 745,605 Jul 31 04:34 PM Vartanian Nishan J. CEO Jul 30 '24 Sale 188.00 6,055 1,138,340 35,898 Jul 31 10:48 AM NISHAN J VARTANIAN & PAMEL A Non-Executive Director Jul 30 '24 Proposed Sale 188.00 6,055 1,138,340 Jul 30 04:39 PM Vartanian Nishan J. CEO May 02 '24 Sale 185.29 11,000 2,038,146 56,800 May 03 11:06 AM Vartanian Nishan J. CEO Mar 12 '24 Sale 185.75 4,099 761,385 67,800 Mar 14 03:33 PM Buck Jonathan D. Chief Accounting Officer Mar 11 '24 Sale 185.50 305 56,578 3,506 Mar 12 09:50 AM Vartanian Nishan J. CEO Mar 01 '24 Sale 182.85 10,630 1,943,728 51,869 Mar 04 04:13 PM Roberts Rebecca B Director Feb 27 '24 Sale 181.84 1,100 200,018 8,474 Feb 28 09:18 AM
Index -
P/E 14.01
EPS (ttm) 0.41
Insider Own 14.30%
Shs Outstand 11.42M
Perf Week -2.87%
Market Cap 64.23M
Forward P/E -
EPS next Y -
Insider Trans -2.56%
Shs Float 9.58M
Perf Month 7.88%
Income 4.71M
PEG 0.93
EPS next Q -
Inst Own 29.38%
Short Float 1.39%
Perf Quarter 16.40%
Sales 61.09M
P/S 1.05
EPS this Y -
Inst Trans -6.78%
Short Ratio 3.40
Perf Half Y -3.04%
Book/sh 5.58
P/B 1.03
EPS next Y -
ROA 6.88%
Short Interest 0.13M
Perf Year 25.30%
Cash/sh 1.45
P/C 3.96
EPS next 5Y 15.00%
ROE 7.65%
52W Range 3.93 - 6.92
Perf YTD 8.70%
Dividend Est. -
P/FCF 13.49
EPS past 5Y 6.28%
ROI 6.69%
52W High -16.91%
Beta -0.72
Dividend TTM -
Quick Ratio 17.19
Sales past 5Y 15.22%
Gross Margin 37.73%
52W Low 46.31%
ATR (14) 0.22
Dividend Ex-Date -
Current Ratio 28.43
EPS Y/Y TTM 81.94%
Oper. Margin 7.25%
RSI (14) 45.96
Volatility 2.95% 3.72%
Employees 124
Debt/Eq 0.15
Sales Y/Y TTM 7.43%
Profit Margin 7.71%
Recom -
Target Price -
Option/Short Yes / Yes
LT Debt/Eq 0.13
EPS Q/Q 53.46%
Payout 0.00%
Rel Volume 0.55
Prev Close 5.82
Sales Surprise -
EPS Surprise -
Sales Q/Q 1.08%
Earnings Mar 13 BMO
Avg Volume 39.08K
Price 5.75
SMA20 -2.84%
SMA50 -0.89%
SMA200 3.89%
Trades
Volume 21,315
Change -1.20%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-30-10 Downgrade
Dougherty & Company
Buy → Neutral
$5 → $2.50
Oct-16-09 Initiated
Dougherty & Company
Buy
$10
Aug-07-24 09:00AM
May-08-24 09:00AM
Apr-03-24 11:30AM
Mar-25-24 07:00PM
(GuruFocus.com) -7.20%
+5.65%
Mar-13-24 09:00AM
09:00AM
Loading…
Nov-27-23 09:00AM
Nov-07-23 03:21PM
09:00AM
Aug-08-23 09:00AM
Jun-22-23 03:30PM
May-09-23 09:00AM
Apr-21-23 02:37PM
Mar-16-23 09:00AM
Dec-28-22 02:33PM
Dec-15-22 09:00AM
11:37AM
Loading…
Nov-12-22 11:37AM
Nov-07-22 09:00AM
Aug-04-22 09:00AM
Jun-23-22 09:00AM
May-10-22 09:00AM
May-06-22 06:40AM
Mar-09-22 09:00AM
Jan-20-22 09:38AM
Dec-24-21 01:38AM
Dec-17-21 11:38PM
12:38PM
Dec-15-21 09:00AM
Dec-11-21 05:38AM
Nov-04-21 09:00AM
Aug-04-21 09:00AM
10:26AM
Loading…
Jun-30-21 10:26AM
May-24-21 09:00AM
May-06-21 10:20AM
09:00AM
Apr-28-21 12:34PM
Mar-19-21 08:32AM
Mar-17-21 11:47AM
Mar-16-21 12:36PM
Mar-09-21 10:15AM
09:00AM
Feb-27-21 02:50AM
Feb-04-21 02:04PM
(Investor's Business Daily)
Jan-19-21 11:19PM
Dec-16-20 11:17AM
Dec-14-20 11:23PM
Dec-02-20 09:47PM
Nov-15-20 07:16AM
Nov-13-20 09:23AM
08:41AM
Nov-05-20 09:00AM
Nov-02-20 02:15PM
(Investor's Business Daily) +7.54%
Oct-23-20 09:00AM
Oct-19-20 05:03PM
04:15PM
Oct-16-20 06:38AM
Oct-15-20 09:15AM
Oct-08-20 09:15AM
Oct-07-20 09:15AM
Oct-01-20 09:15AM
Sep-28-20 09:15AM
Sep-25-20 09:15AM
Sep-24-20 09:15AM
Sep-22-20 09:15AM
09:00AM
Sep-20-20 08:39AM
Aug-25-20 06:01AM
Aug-04-20 03:00PM
12:26PM
09:00AM
06:02AM
Jul-31-20 02:14PM
Jul-20-20 04:03PM
Jul-17-20 06:27AM
Jul-13-20 02:05PM
Jun-26-20 03:00PM
Jun-25-20 09:00AM
Jun-19-20 03:16PM
Jun-10-20 04:07PM
(Investor's Business Daily) +9.47%
+12.16%
03:29PM
May-22-20 06:46AM
May-15-20 07:54AM
May-06-20 09:00AM
Apr-22-20 06:21AM
Apr-09-20 03:30PM
10:49AM
Apr-08-20 04:06PM
(Investor's Business Daily) +5.52%
03:29PM
07:28AM
06:45AM
Mar-29-20 08:21AM
Mar-16-20 04:08PM
(Investor's Business Daily) +5.04%
-5.94%
Mar-13-20 10:23AM
Mar-12-20 08:07AM
06:45AM
Mar-11-20 07:54AM
(Simply Wall St.) +23.89%
Mar-07-20 11:20AM
Mar-06-20 09:57AM
06:00AM
Mar-04-20 10:33AM
Mar-03-20 04:28PM
Alpha Pro Tech Ltd. engages in the business of protecting people, products and environment. It develops, manufactures and markets disposable and limited use protective apparel products for the industries, clean room, medical and dental markets. The company operates through the Disposable Protective Apparel and Building Supply segments. The Disposable Protective Apparel segment includes many different styles of disposable products, such as shoe covers, bouffant caps, gowns, coveralls, lab coats, frocks and other miscellaneous products. The Building Supply segment consists of a line of construction supply weatherization products, namely house wrap and synthetic roof underlayment. The company was founded in 1983 and is headquartered in Markham, Canada.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
MCDONALD COLLEEN J CFO Mar 21 '24 Sale 6.16 20,000 123,100 55,833 Mar 25 03:50 PM RITOTA JOHN Director Mar 21 '24 Option Exercise 3.42 15,000 51,300 61,463 Mar 22 05:13 PM RITOTA JOHN Director Mar 20 '24 Sale 5.97 6,181 36,901 55,282 Mar 22 05:13 PM RITOTA JOHN Director Mar 21 '24 Sale 5.94 819 4,865 54,463 Mar 22 05:13 PM Millar Donna Director Mar 18 '24 Option Exercise 3.62 15,000 54,300 1,299,603 Mar 20 10:09 AM HOFFMAN LLOYD CEO AND PRESIDENT Mar 18 '24 Option Exercise 3.62 100,000 362,000 222,505 Mar 20 09:52 AM MCDONALD COLLEEN J CFO Mar 18 '24 Option Exercise 3.62 30,000 108,600 75,833 Mar 20 09:20 AM Buchan James Director Mar 15 '24 Option Exercise 3.42 15,000 51,300 21,013 Mar 19 11:30 AM Buchan James Director Mar 15 '24 Sale 5.82 15,000 87,260 6,013 Mar 19 11:30 AM MONTGOMERY CHARLES D Director Mar 14 '24 Option Exercise 3.62 33,333 120,665 84,167 Mar 18 03:26 PM Buchan James Director Sep 08 '23 Option Exercise 3.60 10,000 36,000 16,013 Sep 12 03:03 PM Buchan James Director Sep 08 '23 Sale 4.46 10,000 44,600 6,013 Sep 12 03:03 PM
Index RUT
P/E 142.89
EPS (ttm) 0.17
Insider Own 2.39%
Shs Outstand 46.17M
Perf Week -1.74%
Market Cap 1.09B
Forward P/E 13.06
EPS next Y 1.82
Insider Trans -0.68%
Shs Float 44.85M
Perf Month 5.47%
Income 7.70M
PEG 22.68
EPS next Q 0.35
Inst Own 93.60%
Short Float 1.63%
Perf Quarter 17.66%
Sales 682.40M
P/S 1.60
EPS this Y 34.63%
Inst Trans -0.42%
Short Ratio 3.32
Perf Half Y 20.47%
Book/sh 26.62
P/B 0.89
EPS next Y 31.01%
ROA 0.42%
Short Interest 0.73M
Perf Year 16.27%
Cash/sh 2.01
P/C 11.82
EPS next 5Y 6.30%
ROE 0.57%
52W Range 17.24 - 24.77
Perf YTD 5.75%
Dividend Est. -
P/FCF 26.07
EPS past 5Y -
ROI 0.54%
52W High -4.24%
Beta 0.90
Dividend TTM -
Quick Ratio 1.49
Sales past 5Y 0.78%
Gross Margin 55.82%
52W Low 37.63%
ATR (14) 0.61
Dividend Ex-Date -
Current Ratio 2.28
EPS Y/Y TTM 121.93%
Oper. Margin 10.43%
RSI (14) 56.21
Volatility 2.33% 2.38%
Employees 3771
Debt/Eq 0.18
Sales Y/Y TTM -12.59%
Profit Margin 1.13%
Recom 2.67
Target Price 25.50
Option/Short Yes / Yes
LT Debt/Eq 0.16
EPS Q/Q 102.69%
Payout -
Rel Volume 0.57
Prev Close 24.13
Sales Surprise 0.61%
EPS Surprise 1.15%
Sales Q/Q 1.36%
Earnings Jul 31 BMO
Avg Volume 220.18K
Price 23.72
SMA20 1.31%
SMA50 6.34%
SMA200 15.89%
Trades
Volume 125,907
Change -1.70%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-25-23 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
May-22-23 Initiated
CL King
Buy
$31
Aug-04-21 Downgrade
Stephens
Overweight → Equal-Weight
$60 → $45
Apr-13-20 Upgrade
Barclays
Underweight → Equal Weight
$30
Nov-07-19 Downgrade
Stifel
Buy → Hold
$45 → $35
Nov-06-19 Downgrade
Raymond James
Outperform → Mkt Perform
Oct-16-18 Initiated
Barclays
Equal Weight
$69
Aug-21-18 Upgrade
Raymond James
Mkt Perform → Outperform
Aug-22-24 09:40AM
Aug-12-24 10:36AM
Aug-05-24 09:40AM
Aug-01-24 12:55PM
Jul-31-24 08:20AM
07:16AM
Loading…
07:16AM
(Associated Press Finance)
07:00AM
Jul-26-24 12:43PM
Jul-24-24 06:14PM
Jul-01-24 07:00AM
May-13-24 07:15AM
May-06-24 10:54AM
May-03-24 01:14PM
04:21AM
03:31AM
11:56AM
Loading…
May-02-24 11:56AM
08:47AM
08:25AM
07:24AM
(Associated Press Finance)
07:00AM
Apr-25-24 11:16AM
Apr-02-24 11:18AM
Feb-21-24 07:18PM
09:37AM
08:59AM
Feb-20-24 07:36AM
07:34AM
(Associated Press Finance)
07:00AM
Feb-13-24 08:41PM
Jan-05-24 10:15AM
08:00AM
Loading…
Jan-04-24 08:00AM
Jan-02-24 10:53AM
Dec-01-23 11:31AM
Nov-07-23 01:08PM
Nov-05-23 12:33PM
Nov-02-23 12:25PM
Nov-01-23 10:21PM
(Thomson Reuters StreetEvents) +13.24%
09:14AM
07:42AM
(Associated Press Finance)
07:00AM
Oct-31-23 08:32AM
Oct-25-23 10:02AM
09:30AM
Sep-12-23 06:37AM
Aug-11-23 10:50AM
06:07AM
Aug-10-23 11:22AM
01:25AM
(Thomson Reuters StreetEvents)
Aug-09-23 08:50AM
07:45AM
(Associated Press Finance)
07:00AM
Aug-08-23 06:52PM
Aug-02-23 12:31PM
Aug-01-23 09:12AM
Jul-24-23 11:40AM
Jul-03-23 08:15AM
Jun-28-23 04:11PM
Jun-21-23 08:00PM
11:10AM
Jun-19-23 01:00PM
Jun-13-23 08:00AM
Jun-08-23 11:30AM
06:50AM
Jun-07-23 11:38AM
May-22-23 06:27AM
May-05-23 02:49PM
11:12AM
May-03-23 10:58PM
(Thomson Reuters StreetEvents) -15.61%
11:59AM
08:15AM
07:06AM
07:00AM
May-02-23 08:02AM
May-01-23 05:35PM
Apr-28-23 11:25AM
Apr-27-23 10:41AM
10:34AM
08:13AM
Apr-26-23 08:00PM
10:50AM
10:49AM
09:53AM
Apr-25-23 12:10PM
09:44AM
Apr-24-23 10:24AM
09:40AM
Apr-21-23 01:31PM
11:35AM
09:40AM
Apr-20-23 10:41AM
10:37AM
Apr-19-23 11:30AM
10:26AM
10:03AM
08:53AM
Apr-18-23 12:28PM
Apr-17-23 10:00AM
08:05AM
Apr-14-23 11:16AM
10:31AM
Avanos Medical, Inc. is a medical technology company, which engages in delivering clinically superior medical device solutions and products to healthcare providers and patients. The company was founded on February 25, 2014 and is headquartered in Alpharetta, GA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Greiner Michael SVP - Chief Financial Officer Mar 18 '24 Option Exercise 0.00 4,219 0 155,714 Mar 19 04:11 PM Holbrook Kerr SVP, Chief Commercial Officer Mar 18 '24 Option Exercise 0.00 2,531 0 89,727 Mar 19 04:10 PM Woody Joseph Fralin Chief Executive Officer Mar 18 '24 Option Exercise 0.00 15,821 0 453,810 Mar 19 04:09 PM Greiner Michael SVP - Chief Financial Officer Mar 14 '24 Sale 19.12 8,000 152,980 151,495 Mar 15 11:40 AM Shimer Julie Ann Director Mar 11 '24 Buy 19.85 500 9,925 50,090 Mar 11 05:15 PM
Index S&P 500
P/E 37.52
EPS (ttm) 5.89
Insider Own 6.86%
Shs Outstand 75.08M
Perf Week -5.95%
Market Cap 16.52B
Forward P/E 21.02
EPS next Y 10.52
Insider Trans 0.13%
Shs Float 69.57M
Perf Month 8.39%
Income 447.03M
PEG 3.95
EPS next Q 2.31
Inst Own 87.76%
Short Float 3.92%
Perf Quarter -14.10%
Sales 3.94B
P/S 4.19
EPS this Y 9.08%
Inst Trans -1.41%
Short Ratio 3.25
Perf Half Y -28.84%
Book/sh 50.31
P/B 4.40
EPS next Y 12.05%
ROA 7.27%
Short Interest 2.73M
Perf Year -40.18%
Cash/sh 10.47
P/C 21.12
EPS next 5Y 9.50%
ROE 12.09%
52W Range 176.34 - 370.41
Perf YTD -19.29%
Dividend Est. -
P/FCF 40.82
EPS past 5Y 3.39%
ROI 11.59%
52W High -40.30%
Beta 1.64
Dividend TTM -
Quick Ratio 1.06
Sales past 5Y 16.58%
Gross Margin 70.33%
52W Low 25.41%
ATR (14) 8.86
Dividend Ex-Date -
Current Ratio 1.18
EPS Y/Y TTM 45.02%
Oper. Margin 17.34%
RSI (14) 43.20
Volatility 3.94% 3.63%
Employees 21610
Debt/Eq 0.03
Sales Y/Y TTM 5.50%
Profit Margin 11.34%
Recom 2.06
Target Price 291.09
Option/Short Yes / Yes
LT Debt/Eq 0.03
EPS Q/Q -11.95%
Payout 0.00%
Rel Volume 0.76
Prev Close 226.52
Sales Surprise -0.89%
EPS Surprise 3.15%
Sales Q/Q 2.63%
Earnings Jul 24 AMC
Avg Volume 838.96K
Price 221.15
SMA20 -3.34%
SMA50 -5.43%
SMA200 -16.96%
Trades
Volume 635,754
Change -2.37%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-26-24 Initiated
Leerink Partners
Market Perform
$310
Dec-11-23 Downgrade
Goldman
Neutral → Sell
$197
Oct-27-23 Downgrade
UBS
Buy → Neutral
$200
Feb-02-23 Upgrade
Goldman
Sell → Neutral
$165 → $307
Jul-28-22 Downgrade
Goldman
Buy → Sell
$380 → $250
Jan-31-22 Upgrade
UBS
Neutral → Buy
$880 → $620
Jan-31-22 Initiated
Morgan Stanley
Overweight
$575
Oct-01-21 Resumed
Credit Suisse
Outperform
$732
Aug-05-21 Resumed
Credit Suisse
Outperform
$732
Jul-09-21 Upgrade
Stephens
Equal-Weight → Overweight
$600 → $700
Jul-08-21 Initiated
Exane BNP Paribas
Outperform
$790
Apr-22-21 Upgrade
Berenberg
Hold → Buy
$683
Jan-04-21 Upgrade
Evercore ISI
In-line → Outperform
$625
Jul-29-20 Downgrade
Berenberg
Buy → Hold
$306
Jul-20-20 Downgrade
BofA Securities
Neutral → Underperform
$280
Jan-09-20 Upgrade
Wolfe Research
Peer Perform → Outperform
Oct-24-19 Reiterated
BofA/Merrill
Neutral
$220 → $240
Oct-07-19 Downgrade
Guggenheim
Buy → Neutral
Jul-25-19 Downgrade
Evercore ISI
Outperform → In-line
$340 → $220
May-30-19 Initiated
Wolfe Research
Peer Perform
Show Previous Ratings
Sep-04-24 04:01PM
Sep-03-24 06:10PM
Aug-23-24 11:30AM
Aug-22-24 04:00PM
Aug-08-24 10:00AM
11:09AM
Loading…
Aug-06-24 11:09AM
Aug-03-24 01:02AM
Jul-25-24 09:23AM
09:14AM
08:30AM
(Thomson Reuters StreetEvents)
12:30AM
Jul-24-24 05:30PM
05:15PM
04:15PM
(Associated Press Finance)
04:05PM
04:00PM
Loading…
04:00PM
Jul-22-24 06:08AM
Jul-19-24 09:49AM
Jul-17-24 10:01AM
09:00AM
Jul-09-24 06:25AM
Jul-02-24 12:32PM
Jun-25-24 06:15AM
Jun-17-24 05:01PM
Jun-11-24 01:01PM
Jun-10-24 09:56AM
Jun-03-24 08:30AM
May-24-24 11:31AM
May-22-24 08:19PM
05:00PM
09:35AM
Loading…
May-20-24 09:35AM
May-16-24 11:43AM
May-15-24 10:49AM
May-13-24 01:53PM
May-11-24 07:11AM
May-06-24 09:40AM
Apr-29-24 05:07PM
Apr-26-24 08:37AM
08:30AM
Apr-25-24 01:41PM
12:14PM
11:34AM
08:18AM
06:51AM
(Thomson Reuters StreetEvents)
03:21AM
Apr-24-24 11:00PM
05:33PM
05:30PM
05:10PM
04:27PM
04:08PM
(Associated Press Finance)
04:01PM
Apr-22-24 09:16AM
Apr-18-24 10:53AM
Apr-16-24 11:51AM
Apr-10-24 11:10AM
Apr-08-24 08:00AM
Apr-04-24 08:24AM
Apr-02-24 09:40AM
Apr-01-24 03:00PM
08:30AM
Mar-28-24 04:18PM
Mar-26-24 08:44AM
Mar-19-24 02:07PM
Mar-10-24 10:08AM
Mar-01-24 11:30AM
Feb-29-24 12:06AM
Feb-26-24 03:14AM
Feb-22-24 10:17AM
12:42AM
Feb-21-24 11:58AM
Feb-18-24 01:26PM
Feb-09-24 07:44AM
Feb-06-24 07:00PM
04:08AM
Feb-02-24 08:30AM
Feb-01-24 04:30PM
04:20PM
(Investor's Business Daily)
01:09PM
12:44PM
11:43AM
11:09AM
07:45AM
06:35AM
(Thomson Reuters StreetEvents)
12:18AM
Jan-31-24 08:00PM
07:30PM
04:41PM
(Investor's Business Daily)
04:20PM
(Associated Press Finance)
04:05PM
04:00PM
04:00PM
Jan-26-24 09:15AM
Jan-24-24 06:31AM
Jan-17-24 08:01AM
Jan-15-24 07:37AM
Jan-03-24 04:02PM
Jan-02-24 08:30AM
Dec-27-23 11:02AM
Dec-25-23 04:00AM
Align Technology, Inc. engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner, and Scanner and Services segments. The Clear Aligner segment consists of Invisalign full, teen, and assist products, and Vivera retainers for treating malocclusion. The Scanner and Services segment consists of intraoral scanning systems such as single hardware platforms and restorative or orthodontic software options, ancillary products, and other related additional services. The company was founded by Zia Chishti, Brian Freyburger, and Kelsey Wirth in March 1997 and is headquartered in Tempe, AZ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
LARKIN C RAYMOND JR Director Aug 15 '24 Buy 235.33 6,500 1,529,645 28,247 Aug 19 06:35 PM Poul Mojdeh Director May 22 '24 Option Exercise 0.00 660 0 660 May 24 04:12 PM Conroy Kevin T Director May 22 '24 Option Exercise 0.00 660 0 660 May 24 04:11 PM SIEGEL SUSAN E Director May 17 '24 Option Exercise 0.00 1,029 0 7,830 May 21 07:22 PM LACOB JOSEPH Director May 17 '24 Option Exercise 0.00 1,029 0 133,023 May 21 07:07 PM Myong Anne Director May 17 '24 Option Exercise 0.00 1,029 0 6,937 May 21 07:06 PM Saia Andrea Lynn Director May 17 '24 Option Exercise 0.00 1,029 0 14,425 May 21 07:05 PM Dallas Kevin J Director May 17 '24 Option Exercise 0.00 1,029 0 13,275 May 21 07:03 PM MORROW GEORGE J Director May 17 '24 Option Exercise 0.00 1,029 0 2,143 May 21 07:02 PM LARKIN C RAYMOND JR Director May 17 '24 Option Exercise 0.00 1,372 0 21,747 May 21 07:01 PM LACOB JOSEPH Director Feb 29 '24 Sale 303.22 15,000 4,548,308 131,994 Feb 29 06:50 PM LACOB JOSEPH Director Feb 27 '24 Sale 313.01 10,000 3,130,075 146,994 Feb 29 06:50 PM HOGAN JOSEPH M PRESIDENT AND CEO Feb 20 '24 Option Exercise 0.00 19,574 0 228,327 Feb 22 07:56 PM Wright Emory EVP, GLOBAL OPERATIONS Feb 20 '24 Option Exercise 0.00 3,533 0 10,049 Feb 22 07:51 PM Wright Emory EVP, GLOBAL OPERATIONS Feb 07 '24 Sale 287.45 2,524 725,533 709 Feb 09 06:19 PM HOGAN JOSEPH M President and CEO Nov 09 '23 Buy 192.50 5,194 999,845 208,664 Nov 09 08:35 PM HOGAN JOSEPH M President and CEO Oct 31 '23 Buy 188.00 5,319 999,972 203,470 Nov 01 05:18 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite